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Online summary: This protocol uses intravascular Evans blue labeling and Isolectin-B4 
endothelial tip cell staining combined with antibody-based protein detection to monitor new 
blood vessel formation from tip cell selection to functional, perfused blood vessels.  
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ABSTRACT 
During development and in various diseases of the central nervous system (CNS), new blood 
vessel formation starts with endothelial tip cell selection and vascular sprout migration, 
followed by the establishment of functional, perfused blood vessels. Here, we describe a 
method that allows assessment of these distinct angiogenic steps together with antibody-based 
protein detection in the postnatal mouse brain. Intra- and perivascular markers such as Evans 
blue, Isolectin B4 or Laminin are used alongside simultaneous immunofluorescence on the 
same sections. Using confocal laser scanning microscopy and stereological methods for 
analysis, detailed quantification of the three-dimensional postnatal brain vasculature for 
perfused and non-perfused vessels (e.g. vascular volume fraction, vessel length and number, 
number of branch points, perfusion status of the newly formed vessels) and characterization 
of sprouting activity (e.g. endothelial tip cell density, filopodia number) can be obtained. The 
entire protocol, from mouse perfusion to vessel analysis, takes approximately 10d. 
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INTRODUCTION 
The formation of new blood vessels can occur via different mechanisms1-3. Vasculogenesis 
describes the de novo formation of blood vessels during embryonic development, via 
differentiation of angioblasts (endothelial progenitor cells) into endothelial cells and 
subsequent assembly of these endothelial cells into a vascular network1,2. In contrast, 
sprouting angiogenesis is defined as the formation of new blood vessels from pre-existing 
ones, occurs throughout the entire life in various physiological and pathological conditions1,2, 
and involves a range of complex cellular events such as cell adhesion, sprout initiation, 
migration, proliferation, tube formation and anastomosis1,2. A third – although less frequent - 
mechanism of physiological vessel formation that can also occur throughout the entire 
lifespan is the process of intussusception, during which pre-existing vessels split and give rise 
to daughter vessels1,4,5. The relative importance of these three modes of vessel formation 
varies between organs1,2,6. 
 
Angiogenesis in the postnatal mouse brain 
In the mouse CNS, vascularization starts with formation of the perineural vascular plexus via 
vasculogenesis at the ventral neural tube at around embryonic day 7.5 – 8.5 (E7.5 – E8.5)7-9. 
Subsequently, at around E9.5, endothelial sprouts emerging from the perineural vascular 
plexus invade the CNS parenchyma in a caudal to cranial direction and vascularize the CNS 
tissue mainly via sprouting angiogenesis7-10. While these vessel sprouts migrate towards the 
ventricles, further sprouting and branching of the newly formed vessels takes place, thereby 
forming the CNS vessel network7,9. This occurs not only during embryonic development of 
the CNS7,9 but also continues at the postnatal stage11,12. Postnatally, sprouting angiogenesis 
and vascular branching further expand and remodel the three-dimensional CNS 
vasculature11,12. Other perivascular cell types such as vascular smooth muscle cells and 
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pericytes are recruited and finally stabilize the newly formed blood vessels5,10 thereby 
establishing the mature functional CNS vasculature4,7. 
The vascular network of the CNS parenchyma is established via sprouting angiogenesis which 
is driven by a subset of endothelial cells found at the leading edge of the vascular sprout that 
are called endothelial tip cells. These cells sense with their filopodia environmental cues to 
guide the blood vessel sprout towards gradients of angiogenic growth factors like VEGF or 
bFGF1,2. Tip cells are followed by endothelial stalk cells, which proliferate and form the 
vascular lumen, thereby elongating the vascular sprout1,2,13,14. After fusion of neighboring 
sprouts, lumen formation allows perfusion of the newly formed vessel1,2,15-18. Subsequently, 
endothelial cells in the newly formed blood vessels resume a quiescent state, the so-called 
phalanx cells, and the now mature blood vessel reaches a functional stage1,2,19. Importantly, 
vessels that are unable to become perfused, regress1,2,20. 
 
Towards mature, perfused blood vessels – the postnatal mouse brain as a model 
During postnatal brain development, angiogenesis is quite active11,12,21,22, thus, providing an 
interesting model system to study sprouting angiogenesis, the predominant mode of vessel 
formation in the brain7,8. Similar to axonal growth cones, endothelial tip cells are guided by 
the interplay of attractive and repulsive cues involving for instance the axonal guidance 
molecules Netrins, Semaphorins, Slits and Ephrins as well as the neural growth inhibitor 
Nogo-A3,8,12. An increased number of vascular sprouts and endothelial tip cells can result in 
an increased number of perfused blood vessels23 as we have for instance shown for animals 
lacking functional Nogo-A12. Initially, the balance between endothelial tip and stalk cell 
numbers and the balance between tip migration and stalk proliferation affect branching 
frequency and plexus density24. The transition from sprouting endothelial tip cells to 
functional, perfused blood vessels is mainly regulated by the VEGF-VEGFR-Dll4-Jagged1-
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Notch pathway1,2,13,18,24-26. Disturbance of these processes can lead to non-productive 
angiogenesis and aberrant blood vessels23,26-29. However, the final functionally perfused 
vascular network seems to be remodeled depending on many factors including metabolic and 
mechanical feedback from the surrounding tissue and the flowing blood respectively20, that 
are not completely understood so far18. For example, in tumor angiogenesis, blockade of Dll4-
Notch signaling that normally limits the number of tip cells and filopodia leads to more 
filopodial protrusions and finally more blood vessels. However, these vessels are hypo- or 
non-perfused, e.g. not functional, thus resulting in reduced instead of the initially expected 
increased tumor growth26,28-30. Consequently, vessel density and tumor growth showed no 
correlation in these studies26,28-30. 
These findings underline the need for a  detailed analysis to address the different angiogenic 
steps including endothelial tip cell selection, vascular density and perfusion status of blood 
vessels. Presently there is no established protocol to precisely and quantitatively distinguish 
between perfused and newly forming blood vessels including vascular endothelial tip cells. 
However, such a protocol is crucial in order to investigate the mechanical and metabolic 
feedback finally responsible for maturation as well as for stability of functional vascular 
networks20. Precise co-localization of the perfusion status of the (newly forming) capillaries 
with endothelial tip cell morphology as well as with the molecular machinery driving 
angiogenesis  has been problematic, contributing to the incomplete current knowledge on 
vascular network maturation. The protocol presented here addresses this issue and correlates 
the in vivo perfusion status of the vasculature (not postmortem perfusion of fixed animals) 
with angiogenic events in the three-dimensional (3D) vascular network of the developing 
postnatal mouse brain. 
 
Development of the protocol 
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Capillary development in the postnatal rat brain has been described previously11 and the 
analysis of total versus perfused vascular network in the adult rat brain was analyzed using a 
combination of immunfluorescence staining against Fibronectin (FN) to visualize the total 
vessel tree and intravascular Evans blue (EB) injection to label perfused vessels31. Recently, 
we have identified Nogo-A as a negative regulator of angiogenesis and endothelial tip cell 
number in various regions of the postnatal mouse brain by using IB4 to label the existing 
vessels as well as endothelial tip cells and intravitally injected EB to assess the portion of 
perfused vessels12. However, in this study, EB+ and IB4+ vessel structures were quantified 
using a computer-controlled, microscope stage on 10 !m coronal brain sections, whereas the 
number of endothelial tip cells was addressed in a separate group of mice on 40 !m free-
floating coronal brain sections using a different staining- and fixation protocol optimized to 
visualize endothelial tip cells and their filopodial protrusions12. 
Here, we demonstrate an optimized combination of these methods, thereby allowing 
simultaneous visualization and quantification of endothelial tip cells, the total vascular 
network and functional, perfused blood vessels. Using design-based stereological methods  
we provide absolute parameters characterizing the postnatal 3D mouse brain vessel network. 
Applications of the protocol 
The presented protocol distinguishes between EB+/IB4+ perfused vessels and the total IB4+ 
vasculature including newly formed vessel sprouts with endothelial tip cells (vascular sprouts 
are EB+/IB4+ or EB-/IB4+). Importantly, the method can be combined with 
immunofluorescence to correlate the expression of virtually any protein of interest with the 
developing 3D vessel structures. The protocol can be used to study the influence of any 
angiogenic or other molecule in relation to the ratio of perfused and non-perfused vessels and 
endothelial tip cells in the postnatal mouse brain. Moreover, pro- or anti-angiogenic effects of 
pharmacological compounds, peptides or blocking antibodies on the developing postnatal 
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brain vasculature can easily be tested in wild-type or genetically modified mice12 and 
quantitatively characterized using computer-aided stereological methods (e.g. provided by 
IMARIS, ImageJ, Steroinvestigator, CAST, Stereologer or comparable software). Finally, 
given that angiogenesis plays a crucial role not only during tissue development but also in 
various pathologies in- and outside the CNS1,2,8,42,43 such as hypoxia or malignancies8, the 
method presented here could - after validation in other tissues or pathological conditions - be 
applied in these settings. 
 
Overview of the procedure  
Here, we present a technique for the visualization and quantification of vascular endothelial 
tip cells and functionally perfused vessels in the postnatal mouse brain, Figure 1 shows the 
flow chart of the procedure along with a timescale. The protocol starts with preparation of the 
solutions needed and continues with intracardial Evans Blue injection at the desired day of 
postnatal development (in our case P8), followed by brain dissection, immersion-fixation, 
cryoprotection, cryostat cutting, immunofluorescent stainings, imaging and quantification of 
vascular structures using stereology. 
 
The step-by-step procedure of intracardial EB injection and brain dissection is illustrated in 
Figure 2a-h and in Supplementary Videos 1 and 2). As a first step, mice (e.g. P8) are 
intracardially injected with 6 !l/g body weight of 2% Evans blue. A 30.5G needle is used and 
positioned above the heart ca. 2 mm parasternal to the left at a virtual line connecting both 
armpits, in a caudal and lateral angle of 30° and 10°, respectively (Fig. 2a-b and 
Supplementary Video 1). Successful injection is followed by immediate bluish appearance of 
the paws, snout and tail (Fig. 2c and Supplementary Video 1). After 5–10 min., the brains are 
dissected out of the skull (Fig. 2d-f and Supplementary Video 2) and cut into three coronal 
pieces of ~2 mm thickness (Fig. 2g,h) that are then immersion fixed in 4% formaldehyde (FA) 
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solution made from paraformaldehyde (PFA) with varying contents of glutaraldehyde (GA) 
(two possibilities: 0.025% GA, or 0.05% GA) overnight. This fixation step and especially the 
addition of GA retains the Evans blue in the vessels (see Supplementary Fig. S1 and Tissue 
fixation) and preserves the tissue to allow immunofluorescent staining (see Supplementary 
Fig. S1). After cryoprotection in 30% (w/v) sucrose in 0.1M PB for 2-3 days, brain sections 
are cut and processed free-floating for IB4, DAPI and immunofluorescence staining. We have 
obtained best results with the antigens selected here (e.g. to address blood vessels and 
perivascular cells, see Supplementary Fig. S3) when the primary antibodies were incubated 
(together with IB4 and DAPI) for three days, followed by incubation with secondary 
antibodies overnight (Supplementary Fig. S3, Table 2). Finally, the sections are mounted, 
imaged with a confocal laser scanning microscope and quantitatively analyzed using 
stereological methods. 
We recommend the use of relatively thick (e.g. 40 !m) brain sections to obtain reliable 3D 
information about the blood vessel tree and to quantify vessel parameters such as vessel 
volume fraction, vessel length or vessel branch points (Fig. 5). In addition, more endothelial 
tip cells appear complete (including its entire filopodial tree) in these 40 !m thick brain 
sections (Figs. 3, Fig. 4, Fig. 5, Fig. 6), thereby allowing a complete 3D reconstruction of 
filopodia and quantitative analysis including filopodia number, length and straightness (Fig. 
6).  
 
Experimental design 
This protocol describes the visualization and quantification of vascular endothelial tip cells 
and functionally perfused vessels in the postnatal mouse brain. Figure 1 shows the flow chart 
of the procedure along with a timescale. The protocol starts with preparation of the solutions 
needed and continues with intracardial Evans Blue injection at the desired day of postnatal 
development (in our case P8), followed by brain dissection, immersion-fixation, 
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cryoprotection, cryostat cutting, immunofluorescent stainings, imaging and quantification of 
vascular structures using stereology. 
 
The step-by-step procedure of intracardial EB injection and brain dissection is illustrated in 
Figure 2a-h and in Supplementary Videos 1 and 2). First, mice (e.g. P8) are intracardially 
injected with 6 !l/g body weight of 2% Evans blue using s 30.5G needle that is positioned 
above the heart ca. 2 mm parasternal to the left on a virtual line connecting both armpits, in a 
caudal and lateral angle of 30° and 10°, respectively (Fig. 2a-b and Supplementary Video 1). 
Successful injection results in immediate bluish discoloring of paws, snout and tail (Fig. 2c 
and Supplementary Video 1). After 5–10 min., the brains are dissected out of the skull (Fig. 
2d-f and Supplementary Video 2), cut into three coronal pieces of ~2 mm thickness (Fig. 
2g,h) and immersion fixed overnight in 4% formaldehyde (FA) solution made up of 
paraformaldehyde (PFA) with varying contents of glutaraldehyde (GA) (two possibilities: 
0.025% GA, or 0.05% GA). This fixation step and especially the addition of GA retains the 
Evans blue in the vessels (see Supplementary Fig. S1 and Tissue fixation) and preserves the 
tissue to allow immunofluorescent staining (see Supplementary Fig. S1). After cryoprotection 
in 30% (w/v) sucrose in 0.1M PB for 2-3 days, brains are sectioned and processed free-
floating for IB4, DAPI and immunofluorescence staining. We have obtained best results with 
the antigens selected here (see Table2,  Supplementary Fig. S3) when the primary antibodies 
were incubated (together with IB4 and DAPI) for three days, followed by incubation with 
secondary antibodies overnight. Finally, the sections are mounted, imaged with a confocal 
laser scanning microscope and quantitatively analyzed using stereological methods. 
We recommend using relatively thick (e.g. 40 !m) brain sections to obtain reliable 3D 
information about the blood vessel tree as a prerequisite to quantify vessel parameters such as 
vessel volume fraction, vessel length or branch points (Fig. 5). In addition, more complete 
endothelial tip cells can be found in thicker brain sections (Figs. 3, Fig. 4, Fig. 5, Fig. 6), 
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thereby allowing 3D reconstruction of their entire filopodia tree and its quantitative analysis 
including filopodia number, length and straightness (Fig. 6).  
 
Experimental animals. This protocol can be applied to mice of various postnatal ages; we 
have used P8 here. However, it should be kept in mind that genetic or other manipulations 
(e.g. intraperitoneal antibody or tamoxifen injections) can affect the growth (and in 
consequence the weight) of animals44. Therefore, it is important to measure the animal weight 
prior to EB perfusion because similar weights (and ages) ensure best a comparable 
developmental stage (especially for mouse pups). Because the postnatal development of the 
vasculature is quite fast11, the developmental stage of the mice need to be carefully controlled. 
To this end, age and weight of the animals has to be precisely measured. Littermate controls 
should be used where available but weight match of the animals seems to be an even more 
important parameter with regard to vessel structure analysis since many genetic modifications 
can as a side effect alter the overall postnatal development45.  
In accordance with previous reports9, we recommend to use at least 6 animals per groups. In 
general, the more pronounced a difference between two test groups is, the smaller the number 
of animals to detect this effect becomes and vice versa. When analyzing postnatal CNS 
angiogenesis and vasculature in genetically modified mice, it is essential to incorporate the 
appropriate controls, e.g. including brains from postnatal wild-type littermates. All animal 
procedures must be carried out in accordance with the guidelines outlined by the institutional 
and cantonal review committees for animal experiments. 
 
Evans blue injections. Evans blue binds non-covalently and in low concentrations almost 
completely to serum albumin46. Thus EB stays in place after fixation of all proteins in the 
sample including the intravascular albumin. Therefore, we intracardially inject mice with a 
rather low amount of 6 !l/g body weight of 2% Evans blue that sufficiently stains the 
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vasculature because it is bound almost completely to albumin. At the same time the injected 
amount is low enough to prevent EB diffusion into the brain tissue31,46. The brains are then 
dissected out of the skull and cut into three coronal pieces (Figure 2g,h) to facilitate 
immersion-fixation in 4% FA + 0.025% GA or in 4% FA + 0.05% GA overnight. This 
fixation had to be optimized in order to fulfill two requirements: i) to retain the Evans blue in 
the vessels and, ii) to preserve the tissue by fixation but not “over-fixing” the tissue to allow 
simultaneous visualization of endothelial tip cells and a variety of antigens by 
immunofluorescence (Supplementary Figure S1). 
 
Tissue cutting. For tissue cutting, the brain slices are cut into 40 !m coronal sections on a 
cryostat for free-floating processing. For navigation within the postnatal mouse brain tissue, 
we refer to the Developing Mouse Allen Brain Atlas (http://developingmouse.brain-
map.org/docs/Overview.pdf) (alternatively, any other Brain Atlas can be used) or used 
alternating sections stained with cresyl violet (Nissl stain). 
 
Tissue fixation. We have optimized the simultaneous visualization of perfused blood vessels 
(visualized with Evans blue) and of the total vessel tree including forming blood vessels and 
vascular endothelial tip cells with their filopodia (stained with biotinylated Isolectin B4 (IB4)) 
using different methods of immersion fixation after Evans blue perfusion. 
Previously, after having acquired the EB pictures (for the visualization of the perfused blood 
vessels) in the adult rat brain, EB was washed out by rehydratation31, followed by subsequent 
FN staining to visualize the total (perfused and non-perfused) vessel structures. Moreover, for 
the combined analysis of EB+ perfused blood vessels and IB4+ total vessels (including 
forming vessel sprouts), a specific in-house-developed computer-controlled microscope stage 
was needed that allowed the relocalization of the regions of interest after FN staining and EB 
washout31. In addition, FN antibodies did not label endothelial tip cell (filopodia)31. 
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Moreover, the visualization of endothelial tip cells and the filopodial tree in the postnatal 
mouse brain that we have developed to address the comparison of these structures between P8 
WT and P8 Nogo-A KO animals12 was initially performed on brains from animals that were 
intracardially perfused with 4% FA12, a procedure that would wash away the Evans blue. 
In improving the two above-mentioned methods, we were faced with two problems: 
! how to retain the EB in the tissue if a fixation step using FA in aqueous solution was 
necessary (for good tissue fixation including the endothelial tip cells). An aqueous FA 
solution would wash away the intravascular EB31. 
! how to maintain tissue preservation and to visualize endothelial tip cells in the fragile 
postnatal mouse brain tissue if an intracardial perfusion with 4% FA was not possible, 
because it would wash away the intravascular EB. 
In order to allow the simultaneous visualization of EB+ perfused blood vessels and IB4+ total 
vessels including endothelial tip cells, we tested the following combinations of formaldehyde 
(FA) and Glutaraldehyde (GA) fixatives (Supplementary Fig. S1a-d): i) 4% FA + 0.25% GA, 
ii) 4% FA + 0.05% GA, iii) 4% FA + 0.025% GA and iv) 4% FA alone (no GA). When using 
4% FA alone (no GA) for immersion-fixation, EB was less well retained in the tissue 
(Supplementary Fig. S1a-d). In contrast, the use of 4% FA + 0.25% GA decreased the 
detection sensitivity of endothelial tip cells and especially of their filopodial protrusions. The 
best results for EB-IB4 double visualizations were obtained using 4% FA + 0.05% GA and 
4% FA + 0.025% GA. These combinations also worked well for several antibody stainings, 
e.g. for pericytes (PDGFR"), astrocytes (GFAP), neurons (Nf160), microglia (Iba1) and the 
basement membrane (Laminin) (see Fig. 3g-j, Supplementary Fig. S3 and Table 2 antibodies). 
After cryoprotection in sucrose for 2-3 days, brain sections are cut on a cryostat, taken up in 
buffer and processed free-floating for immunofluorescence staining.  
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Antigen retrieval, background reduction and permeabilization. To decrease background 
staining, a blocking step using either normal serum from the species in which the secondary 
antibodies were raised or IgG-free and protease-free BSA is performed. It is important to 
check the compatibility of the blocking serum with the secondary antibody used. For instance, 
when using primary goat antibodies, one has to replace the normal goat serum of the blocking 
reagent with 2-4% normal horse serum or with IgG-free BSA at 0.5-2%. Permeabilization 
steps are important to improve the antibody/marker penetration into the tissue. We 
permeabilize sections in 0.3% Triton-X for 10 min and use primary antibody solution 
containing 0.05 % Triton-X. We have experienced better endothelial tip cell filopodia 
stainings by introducing the following antigen retrieval steps: Briefly, brain sections are 
incubated in 50 mM NH4Cl in 0.1M phosphate buffer for 30 min at 22°C, followed by 
incubation in 50 mM glycine in 0.1 M Tris (pH 8.0) for 5 min at 80 °C in a microwave 
(600W) to quench aldehyde groups. For antigen unmasking, sections are then incubated in 
CaCl2-containing buffer (0.1 mM CaCl2 + 0.1 mM MgCl2 + 0.1 mM MnCl diluted in 0.1M 
PBS (pH 6.8)) and heated three times for 30s in a microwave (600 W). Furthermore, the 
specificity of the different antibody stainings has to be validated using species-specific IgG 
control antibodies or secondary antibody alone stainings. In addition, verify the absence of the 
signal in a knockout model (if available) or otherwise mimic the knockout phenotype using 
specific inhibitors and blocking peptides. 
 
Vascular labeling. We have obtained best results when antibody staining and biotinylated IB4 
were incubated for three days, followed by incubation with secondary antibodies overnight 
and sufficient washing steps. The brain vasculature is labeled with biotinlyated IB4 (as a 
marker of the total vascular network), with Laminin (as a marker for blood vessels with a 
basement membrane) as well as with in vivo intracardially injected Evans blue to visualize 
perfused vessels46. IB4 from the african-based black bean Griffonia simplicifolia binds with 
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high affinity to #-galactosyl residues of glycoproteins on the cell surface of the endothelium47-
51, thereby allowing the visualization of blood vessel endothelial cells including endothelial 
phalanx, stalk and tip cells as well as endothelial tip cell filopodia in various tissues9,49,52,53. 
For the visualization of endothelial tip cell filopodia, we obtain the best results when using 
biotinylated IB4 diluted 1:50 (20 µg/ml) in CaCl2-containing buffer combined with 
streptavidin–Cy3/streptavidin-Alexa Fluor 543/streptavidin-Dye-light 547 diluted 1:200 in 
CaCl2-containing buffer (see paragraph “procedure”) (Figs. 3-6). Notably, in addition to 
endothelial cells, (biotinylated) IB4 also labels macrophages/microglial cells (Fig. 3g-j), as 
previously described54,55 and we also observed IB4+ microglial cells with the staining protocol 
described here (Fig. 3g-j). To distinguish microglial cells and tissue macrophages from 
endothelial cells, macrophages/microglial cells can specifically be labeled with an anti- Iba1-
antibody (Fig. 3g-j). Laminin is a protein to visualize the basement membrane of blood 
vessels walls1,31 and can be recognized by an anti-Laminin antibody (see Table 2). Evans blue 
is a dye that non-covalently binds to serum albumin and thereby allows investigation of 
functional, perfused vessels31,56. Perivascular cell types of the neurovascular unit such as 
pericytes, astrocytes, neurons and microglia can be stained by corresponding cell type-specific 
antibodies (see Fig. 3, Supplementary Fig. S3 and Table 2 antibodies). 
 
Imaging and quantification. To optimally address the 3D postnatal brain vasculature, we use 
confocal laser scanning microscopy. EB+ and IB4+ vessel structures, volume fraction, length 
and the number of branch points and endothelial tip cells can be quantified with lower 
magnifications (20x, NA 0.7). The resulting images are analyzed using the Stereoinvestigator 
Software (Fig. 5). Visualization and analysis of endothelial tip cell filopodia is performed by 
acquiring 3D stacks using high numerical aperture objectives (e.g. 63x, NA 1.4, Figure 3c-f, 
Figure 4, Figure 6). To analyze endothelial tip cell filopodia (see Box 1), we use the image 
processing software Imaris 7.6.2 (Bitplane) (Fig. 6, Box 1). Briefly, filopodia are traced by 
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the filament module (Figs. 4,6, Box 1) obtaining the following parameters: filopodia number 
per tip cell, filopodia length and filopodia straightness (Fig. 6). 
 
Design-based stereological methods provide direct information about morphological 3D 
parameters of interest, e.g. the length of vessels, the number of vessel branch points or the 
vessel volume fraction. This is in stark contrast to the biologically difficult to interpret but 
commonly used variety of measures like “percent of the area of a section occupied by 
vessels”, “number of pixels occupied in an image” or “measures of length or diameter” in 2D 
projections. The term “Design-based” refers to the mathematical bases of these methods. 
They are mathematically (“proofable”, not empirically) designed to return an accurate value 
of the parameter of interest. If one is interested in vessel length, e.g, spaceballs will return the 
accurate vessel length in the material at hand independent of the orientation, diameter or 
tortuosity of the vessels. They are, like all other methods, only limited by the ability of an 
observer to recognize the structures that are to be measured32. 
Design-based methods are typically presented as “package deals”, i.e. a combination of a 
particular sampling approach (where to measure) with specific probes (how to measure). 
“Uniform random systematic sampling” is the generally best choice of sampling because of its 
efficiency. Using this approach, the tissue is probed at regular (systematic) intervals. In the 
case of tissue sections, these intervals are typically predefined distances along the x- and y-
axes of the sections. To make the sample statistically representative, the first location at which 
the tissue is investigated must be located at random within the first sampling interval. 
Thereafter this tissue is investigated at the systematic intervals that were defined. If n 
measures the need to be performed to obtain a desired precision with a random independent 
sample, typically $n measures, and, therefore, a $time necessary to perform the 
measurements, will be sufficient using a uniform random systematic sample33,34. 
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The easiest mode of how to measure is to count the interactions between vascular features and 
geometric probes, i.e. how many times does a test point fall onto the volume of a vessel, how 
many times does the length of a vessel intersect with a test area or how many vessel branch 
points are contained in a volume probe. Very simple relationship equations33,35 are used to 
convert these counts of interactions to volume, length and number densities, which can then 
be converted to absolute values if the reference volume (ROI volume) or the sampling 
fraction is known. If , e.g., capillaries perforate the surface of 50 spaceball probes36 with a 
surface of 10000 !m2 each 70  times (Q = 70), the relationship equation LV (length density) = 
2Q/A = 140/(50%10000 !m2) provides a length density estimate of 0.00028/!m2. If the ROI 
has a volume of 1 mm3 (109 !m3), an estimate of the total length of capillaries in the ROI is 
0.00028/!m2 % 109 !m3 = 280000 !m. Specialized software packages such as for example 
Stereoinvestigator that we have used here have the advantage that all calculations are taken 
care of. Both, introductory reviews35,37-39 and comprehensive and comprehensible basic 
texts33,40 that explain design-based stereological methods and that include extensive example 
calculations are available. 
Aside from their rigorous mathematical basis and efficiency, design-based stereological 
methods provide access to parameters that would otherwise be difficult if not impossible to 
accurately measure in tissue sections. For instance, we estimated the length of capillary 
segments to have a length of 325 !m. Direct measurements would require the inclusion of the 
entire capillary segment in the section plane. In 40 !m thick tissue sections, capillaries that 
course perpendicular to the section plane cannot be measured, potentially biasing estimates to 
capillary segments with a preferred orientation (in the section plane). Tortuous capillary 
segments would be more likely to be interrupted by the section plane than straight ones, 
potentially biasing estimates to capillaries of a certain shape. Shorter capillary segments 
would be more likely included in the section than longer ones, always generating an 
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underestimate independent of orientation and shape. Any experimental intervention that alters 
the orientation or shape of capillary segments, i.e. 3D vascular architecture, has the potential 
to change estimates of segment length in an unpredictable direction and with unpredictable 
strength and, most importantly, without the need for an actual change of length to be present. 
Aside from obviating the need to generate a sufficiently large sample of capillary segments 
included in the section plane in the first place, the combination of stereological length 
estimates40 with branch point counts41 to derive segment length is free from these potential 
biases.  
 
 
 
Advantages of the protocol compared to alternatives 
The analysis of functional, perfused blood vessels, newly forming blood vessels and 
endothelial tip cells in the postnatal mouse brain described here has several key advantages as 
compared to other methods: 
! This method enables to quantitatively distinguish, simultaneously and within the same 
specimen, between newly forming blood vessels including endothelial tip cells and mature, 
perfused vessels11,12 (Figs. 4,5,6). 
! The protocol used here allows simultaneous immunofluorescence in combination with the 
analysis of the perfusion status of the vasculature and the detection and analysis of vascular 
endothelial tip cells (Fig. 3g-j, Figs. 4,5 and Supplementary Fig. 2). In contrast, previous 
protocols dealing with the distinction between EB+ perfused and IB4+ or FN+ total blood 
vessels11,12, a subsequent analysis of the EB+ and IB4+ or FN+ total vessel structures 
required serial sections or sequential processing of the sections and a precise re-
localization of the analyzed vessel tree between different sections or imaging 
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procedures11,12 Furthermore, a simultaneous analysis of endothelial tip cells on the same 
slides was not possible due to the different fixation protocols., 
! Methods to analyze angiogenesis and endothelial tip cells in- and outside the CNS have 
been described for the embryonic mouse hindbrain9, the postnatal mouse retina44,57, and the 
embryonic zebrafish intersegmental vessels (ISVs)58,59. Moreover, perfused vessels and tip 
cells have been addressed in the retina23,53 and a recent study investigated vessel perfusion 
in the postnatal mouse brain22 but did not show a simultaneous visualization and 
quantification of the sprouting activity. Given the relevance of postnatal brain 
angiogenesis11,12, the concomitant lack of adequate methods to study these processes and 
the still limited knowledge of regulators of postnatal brain angiogenesis12,21, our method 
enlarges the armamentarium to study sprouting angiogenesis from the postnatal retina to 
the postnatal mouse brain.  
! Stereological analysis of confocal z-stacks allows the accurate analysis of the 3D vessel 
structure in the postnatal mouse brain, i.e. it produces true vessel parameters (e.g. at P8; 
see Fig. 5) with direct biological meaning such as true vessel length in a defined volume of 
tissue instead of difficult-to-interpret measures like “percentage of section area occupied 
by vessels”. In contrast, the often-used analysis of maximum intensity projections of tissue 
slides can for example lead. to an overestimation of the vessel density, an error that 
increases with section thickness. Thus, in principle, 3D analysis and stereological 
methods41 resulting in true vessel volume fractions provide more accurate quantifications 
and allow better comparison of different studies.  
! In contrast to section analysis (2D, maximum intensity projections), analysis of 3D images 
obtained from confocal z-stacks using stereological methods allows retrieval of additional 
characteristics of the vascular network such as vessel volume fraction, vessel length and 
number, number of branch points, number of filopodia, filopodia length and straightness 
and number thereof per endothelial tip cell (Fig. 5j-n). 
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! Our protocol allows clear identification of endothelial tip cells, based on morphological 
criteria (see Figs. 3,4,5,6). Several markers for endothelial tip cells such as VEGFR2, 
VEGFR3, Dll4, CxCR4 and CD34 have been proposed in recent years1,2,8,60-66. However, 
there is currently no marker available that selectively labels endothelial tip cells, as all the 
above-mentioned markers also label stalk cells, even though to a lesser extent 
(Suppplementary Fig. S2a-l). IB4 also labels tip and stalk cells, the rest of the vascular 
endothelium as well as microglial cells but using our protocol, the filopodial tree of tip 
cells is nicely displayed thereby allowing tip cell identification. In contrast, the suggested 
tip cell markers VEGFR2, VEGFR3 and Dll4 did not label the entire filopodia tree 
(Supplementary Fig. S2) and would not allow a detailed analysis of the filopodia 
morphology (Fig. 6a-t). Accordingly, the best method to detect endothelial tip cells is still 
based on morphological criteria, e.g. a vascular sprout extending numerous filopodia 
forming “hand-like” structures (e.g. about 8-25 filopodia per cell, Figs. 4,5,6).The 
combination of IB4 with a microglia-specific marker such as Iba1 allows to clearly 
distinguishing microglial cells from endothelial tip cells (Fig. 3g-j, Fig. 4d-f). In addition, 
endothelial tip cells are most often found at the end of non-perfused - thus EB- - capillaries 
(Fig. 4d-f, Fig. 6). 
! High resolution confocal microscopy enables to visualize, quantify and characterize 
endothelial tip cell filopodia and to obtain quantitative parameters such as number of 
filopodia per tip cell, filopodial length and filopodial straightness (Fig. 6q-t). 
! The present protocol can be combined with immunofluorescence using various other 
vascular markers, e.g. pericyte markers (PDGFR", CD13), astrocyte markers (GFAP) or 
neuronal markers (Nf160 and Tub"III) to visualize perivascular cell types (see 
Supplementary Fig. S3), whereas basement membrane markers (Laminin, Fibronectin) 
allow to address yet another feature of vascular maturation, namely the establishment of a 
vascular basement membrane (Fig. 4,5 and Suppplementary Fig S3). In principle, virtually 
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any protein of interest can be analyzed in the morphological context of the developing 
vascular network (see Table 2 for antibodies that we have tested). This was not possible 
with earlier methods11,12. Finally, the technique described here is relatively easy and fast to 
perform and provides highly reproducible results. 
 
 
 
 
Limitations of the method described here 
Despite the advantages described above, the method also has some disadvantages and 
limitations: 
! In contrast to the superficial vascular plexus of the postnatal retina44,57 that forms a two-
dimensional flat vascular structure that can easily be assessed, imaged and analyzed, in 
principle even with a standard fluorescence microscope, the postnatal mouse brain 
vasculature develops in 3D with vessel sprouting occurring in all directions. 
Consequently, for proper analysis, confocal imaging is mandatory resulting in much 
longer image acquisition times and larger data sets. The structural complexity of the 
postnatal mouse brain requires precise navigation within each individual sample in order 
to assure that equivalent brain areas are selected, cut, analyzed and compared. This is 
important because the vascular density and most likely also timing and angiogenic activity 
varies considerably between the brain regions11. Navigation within postnatal mouse brain 
samples as prepared with the present protocol is hampered because no standard 
histological stain such as Nissl or H&E (which would disturb the immunofluorescence) 
can be applied on the same sections. Therefore, for detailed navigation, we recommend to 
refer to the Developing Mouse Allen Brain Atlas or to other commonly used Brain Atlas 
(see also Fig. 3a). 
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! Although the method enables to distinguish between endothelial tip cells, newly formed 
but yet immature blood vessels and functional, perfused vessels, blood flow passing 
through the functional vessels cannot be measured. This is of relevance because it has 
been shown that an increased density of perfused blood vessels does not necessarily result 
in a higher blood flow, e.g. as shown for transgenic overexpression of VEGF165 (= VEGF-
A) in the adult mouse brain67,68. 
! This protocol provides only snapshots of brain angiogenesis at different time-points for 
individual mice and therefore requires a large number of animals to study dynamics of 
angiogenesis over time. However, methods to study in vivo angiogenesis in the developing 
postnatal mouse brain are currently not widely available. In principle, nevertheless, 
methods for “real-time” imaging of the brain vasculature exist69-71 and may in future 
complement our protocol. 
! Similar to the methods addressing angiogenesis in the embryonic hindbrain and postnatal 
retina, the distinction between tip cells and trailing stalk cells is not always clear with our 
method. For example, at the retinal front, it can be difficult to identify which filopodia 
belong to which tip cell. In the postnatal brain, even though endothelial tip cells appear 
very clearly (Fig. 3,4,5,6), it is difficult to precisely delineate the borders between 
different cells. 
! Although diffusion of the intravascularly injected EB into the brain tissue is limited by 
binding of the EB dye to the much larger plasma proteins and the short circulation time, 
some dye extravasation cannot be excluded, for example in experimentally induced 
pathological conditions associated with an impaired blood brain barrier (e.g. stroke, brain 
trauma or malignancies/brain tumors). However, during postnatal mouse brain 
development, we never observed significant EB extravasation around vessel structures 
including angiogenic active vessels that that are supposed to be more leaky more leaky 
than mature vessels, e.g. at the tip cell or directly adjacent vascular segments (cf. Figs. 4i, 
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5b,c,g-i, 6b,g,k,o).Further improvements of the method could include markers of lumen 
formation and endothelial polarization13,18,72,73, as well as new, highly selective markers 
for endothelial tip and stalk cells. 
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MATERIALS 
REAGENTS 
! Isoflurane 5% in oxygen (IsoFluo, Abott, code B506) 
! 10 ml Syringe (Braun) 
! Evans blue dye (Sigma-Aldrich, cat. no. E2129, Dye content & 75%) 
! Paraformaldehyde (PFA; Sigma-Aldrich. cat. no. P6148) 
o ! CAUTION This and some of the chemical substances mentioned below are harmful if inhaled 
and swallowed and are irritating to the eyes, respiratory system and skin. They may cause 
sensitization of skin upon contact. Therefore, in principle, wear protective goggles, clothing 
and gloves as appropriate. Use the chemicals in a fume hood. Carefully read the safety sheets 
of all chemicals used in this protocol. 
! Glutaraldehyde (GA 25%; Polyscience cat.no.01909) 
o ! CAUTION It is harmful if inhaled and swallowed. GA is irritating to the eyes, to the 
respiratory system and to the skin. It may cause sensitization of skin upon contact. Wear 
protective goggles, clothing and gloves as appropriate. Use it in a fume hood. 
! Saline solution 
o 0.9% NaCl in distilled water 
! 0.1M Phosphate Buffered Saline (0.1 M PBS) 
o or PBS tablets (Sigma-Aldrich, cat. no. P4417 
! Triton X-100 (Sigma-Aldrich, cat. no. T8787) 
o ! CAUTION It is harmful if ingested and can cause serious damage to the eyes. Wear 
protective goggles, clothing and gloves as appropriate. 
! 0.1M Tris(hydroxymethyl)aminomethane buffer (Tris; VWR, cat. no. 443864E) 
! Biotinylated Isolectin from Bandeiraea simplicifolia BS-I Isolectin B4 (IB4; final concentration: 20 
µg'mL(1; Sigma-Aldrich, cat. no. L2140) 
o CRITICAL The protocol has been optimized for this lectin (e.g. to visualize endothelial cells 
and endothelial tip cell filopodia), and its use is therefore recommended. Biotinylated IB4 
provided a higher signal-to-noise ratio as compared to non-biotinylated IB4. This was 
especially important to detect endothelial tip cell filopodia. 
! DAPI (1:40,000, Sigma-Aldrich, cat. no. D9542) 
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! Primary antibodies 
o CRITICAL The protocol has been optimized for the primary antibodies listed below (e.g. to 
visualize astrocytes, (GFAP) pericytes (PDGFR"), the basement membrane of blood vessels 
(Laminin), neurons (Nf160) and microglia/macrophages (Iba1)) and it is therefore recommend to 
use these antibodies. 
! Rabbit anti-GFAP antibody (1:1,000; DAKO Cytomation, cat. no. Z0334) 
! Rat anti-PDGFR" antibody (1:200; eBioscience, cat. no. 12 1402) 
! Rabbit anti-Laminin antibody (1:250; Sigma-Aldrich, cat. no. L9393) 
! Rat anti-mouse Nf160 antibody (1:250; Zymed, cat. no. 13-0700) 
! Rabbit anti-mouse/human Iba1 antibody (1:250, Wako, cat. no. 019-19741) 
! Rabbit anti-VEGFR2 antibody (1:1,000; Cell Signaling, cat. no. 2479) 
! Goat anti-VEGFR3 antibody (1:1,000; R&D Systems, cat. no. AF743) 
! Rabbit anti-Dll4 antibody (1:1,000; R&D Systems, cat. no. MAB1389) 
! Secondary antibodies 
o CRITICAL The protocol has been optimized for the secondary antibodies listed below and it is 
therefore recommend to use these antibodies. However, it is possible to choose alternative 
(streptavidin-conjugated) fluorophores. 
! DyLight 594-conjugated streptavidin (1:200, Jackson Laboratories, cat. no. 016-500-084? 
! Horseradish peroxidase (HRP)-tagged rabbit anti-rat secondary antibody (Dako, cat. no. P045) 
! HRP-tagged streptavidin (Dako, cat. no. P0397) 
! Alexa Fluor 488–conjugated goat anti-rabbit secondary antibody (1–2 µg'mL(1, Life Technologies, cat. no. 
A11034) 
! Alexa Fluor 488–conjugated goat anti-mouse secondary antibody (1–2 µg'mL(1, Life Technologies, cat. no. 
A11032) 
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! Alexa Fluor 488–conjugated goat anti-rat secondary antibody (Life Technologies, cat. no. A11006) 
! Alexa Fluor 488–conjugated donkey anti-goat secondary antibody (Life Technologies, cat. no. A11055) 
! 8-day-old mouse pups (WT/Bl6,  male or female).  
o CAUTION: Institutional and governmental ethics regulations concerning rodent use must be 
followed 
! Mounting medium (Dako, cat.no.53023) 
! 2-Methylbutane (Sigma-Aldrich M32631) 
! Tissue Tek (Sakura, cat.no. 4583) 
! Nail Polish (colorless, Migros Switzerland)  
! Distilled water (aqua milipore, MilliQ Synthesis A10) MILLIPORE 
! 5M NaOH 
! Filter paper (Schleicher & Schuell, Type LS14 1/2) 
! Reagent A NaH2PO4  * H20 (Axon lab, Appli Chem, Cas-No 10049-21-5, Ec-nNo.: 2314492) 
! Reagent B Na2HPO4 * 2H20 (Axon lab, Appli Chem, Cas-No.: 10028-24-7, Ec-nNo.: 2314487) 
! Bl6C57 mice, postnatal day 8 (P8) 
 
EQUIPMENT 
! Falcon tubes, 15 ml (BD Falcon, cat. no. 35-2099) 
! Falcon tubes, 50 ml (BD Falcon, cat. no. 352074) 
! 24 well plates (Millipore, cat. no. PSHT010R1) 
! Glass superfrost slides (Menzel Gmbh, cat.no. J1800AMNZ) 
! Dissecting instruments: scissor (Fine Science Tools, cat. no. 14079-10), forceps (Fine Science Tools, cat. 
no. 11065-07), dissection forceps no. 5 (Fine Science Tools, cat. no. 91150-20), spring scissors (Fine 
Science Tools, cat. no. 15000-10) 
! Dissection microscope (Zeiss OPMI1, Zeiss) 
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! Fluorescence microscope (Leica MZ16 F, Leica) coupled to a digital camera (Hamamatsu C4742-95, 
Hamamatsu) 
! Confocal laser scanning microscope SP5 (Leica SP5, Leica)  
o CRITICAL The protocol has been optimized with this confocal microscope, but it is possible 
to choose alternative confocal microscopes (e.g. from Olympus or Zeiss) C 
! Imaging editing software: IMARIS 7.6.4 software (Bitplane Scientific software), Adobe Photoshop CS3 or 
CS5 (Adobe) 
! Stereology software: StereoInvestigator 11.0 software (mbf Bioscience) 
! Transfer pipettes (Sarstedt, cat. no. 86.1171) 
! Erlenmeyer flasks, 250 ml 
! Tabletop balance (e.g. ED Presicion balance, Sartorius) 
! Cryostat (e.g. indications) 
! Water bath (e.g. Stuart SWB15D, Stuart) 
! Tilting table 
 
REAGENT SETUP 
! Evans blue solution (2%, wt/vol): Add 200mg of Evans blue to 10ml of 0.9% saline. and vortex for 3-
5min. The solution should be aliquoted and can be stored at -20°C for unlimited time. Thaw an aliquot at 
room temperature (20-25°C) for use. If an aliquot is not used up completely it can be re-frozen. 
! Formaldehyde solution (FA) (4%, wt/vol in 0.1M PB): Under a chemical fume hood, weigh 8 g of 
paraformaldehyde (PFA)powder into an Erlenmeyer flask and add 100 ml distilled water (aqua milipore). 
Dissolve the PFA powder by heating the solution (containing a clean magnetic stir bar) to 60 °C to facilitate 
dissolving the PFA powder, add few drops of 5 or 10M NaOH when mixing starts. After PFA powder 
dissolved completely, filter the FA solution using a filter paper. To dilute the 8% FA solution to the final 
concentration of 4% FA in 0.1M PB, add 100 ml of 0.2M PB. When the solution has cooled down to room 
temperature, check the pH and adjust to pH 7.4 if necessary. Aliquots can be stored at ( 20 °C for ~3 
weeks44 up to 1 year9, however, we recommend to freshly prepare the 4% FA solution for every experiment. 
Thaw the aliquots at room temperature or at 37 °C in a water bath and cool them to 4° C on ice before use. 
! Glutaraldehyde solution (GA) (0.05% or 0.025%, wt/vol): Dilute from GA stock 25% into the 4% FA 
solution. The GA stock solution can be stored at room temperature for years. 
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! PB (PBS) solution (0.2M): Under a fume hood, weigh 5.24g of reagent A and 18.83g of reagent B into a 1l 
bottle and add 1000 ml of distilled water (aqua milipore). Dissolve this 0.2M PB solution by stirring using a 
magnetic stir bar until reagents A and B have completely dissolved. Check the pH and adjust to pH 7.4 if 
necessary. To obtain 0.1M PBS, dissolve 8g NaCl and add 500 ml of distilled water to 500ml of the 0.2M 
PB solution. PB or PBS should be stored at room temperature for not more than three months. 
! Fixation solution (4% FA + 0.025% or 4% FA + 0.05% GA) : Add GA from the 25% GA stock soluation 
into the 4% FA solution to yield final concentrations of 0.025% GA or of 0.05% GA in 4% FA, 
respectively. 
! 50 mM NH4Cl in 0.1M PB: Dissolve 0.26g ammonium chloride (Merck 1145) in 50 ml distilled water 
added to 50 ml 0.2M PB. Storage at room temperature for less than three months. 
! 50 mM glycine in 0.1 M Tris (pH 8.0): Dissolve 0.38g glycine (Sigma,G8898) and 0.3g TRISMA Base 
(Sigma T6066-5 Kg) in 100ml dest. water and adjust pH to 8.0. Storage at room temperature for less than 
three months. 
! CaCl-containing staining buffer: Add 0.1mM CaCl2, 0.1 mM MgCl2 and 0.1 mM MnCl to 0.1M PBS (pH 
6.8) (slightly modified from Gerhard et al., J Cell Biol, 201353).  Microwave heating solution and primary 
and secondary antibody solution. Storage at room temperature for less than three months. 
! Permeabilization solution: Add 0.3% Triton X-100 to 0.1 M Tris-buffered saline solution (pH 8.0) and stir 
overnight at room temperature. Storage at room temperature for less than three months. 
 
EQUIPMENT SETUP 
! Tilting table: The tilting table should be placed in a fridge or in a cold room, as antibody incubations for 
primary antibodies and for biotinylated IB4 should be performed at 4 °C. Incubation with secondary 
antibodies can alternatively be performed at room temperature. 
! Confocal microscopes: Laser scanning confocal microscopes equipped with -at least - 4 laser lines (405 
nm; 488 nm; 568 nm and 633 nm) and spectral detectors to separate the different fluorochromes were used. 
For the experiments described here, we used a SP5 confocal microscope (Leica Microssystems) but similar 
instruments from other companies can be used. Image stacks were acquired with 20x NA… or 63x NA 1.4 
objectives using an image format of 1024 x1024 pixels. Voxel size for the high-resolution images was: 80 x 
80 x 170 nm. We used sequential scan to detect the nuclei stained with DAPI using a 405 nm laser, for IB4 a 
561 nm laser and for Evans blue a 633 nm laser. The detectors (HyD detectors (Leica) at 12 bit) were set 
between 417- 476 nm, 568 - 674 nm, and 641- 747 nm respectively. For colocalisation studies of blood 
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vessel endothelial cells and perivascular cells and -structures, e.g. astrocytes (e.g. using GFAP as marker), 
pericytes (e.g. using PDGFR" as marker), neurons (e.g. using Nf160 as marker), microglia/macrophages 
(e.g. using Iba1 as a marker) or the basement membrane (e.g. using laminin as marker), combinations of 
primary antibodies and secondary antibodies labeled with Alexa 488 can be used. 
! Stereoinvestigator: see steps 32-37 in “Procedure” 
! Imaris: see steps 38-39 in “Procedure” 
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PROCEDURE 
Animal perfusion with Evans blue (day 1) TIMING ~5-10 min per animal 
1. Anaesthetize P8 mice using 5% Isoflurane in 100% oxygen for 3-5 min. To this end put the animal into a 
syringe (usually they crawl by themselves into the syringe) connected to the Isoflurane vapor). 
o CAUTION: Animal procedures must be carried out in accordance with relevant institutional 
and governmental ethics guidelines. 
2. When the animal is properly anesthetized (test with tail punch) pull it back out of the syringe so that only its 
head stays inside the syringe and turn it on its back. Under a dissecting stereomicroscope, puncture the heart 
of the animal with a 30.5 G needle about 3mm cranial to the xiphoid process and 2mm parasternal (to the 
left) in an angle of about 30° caudally and 10° to the left of the animal, about 5mm deep and inject 6!l per g 
body weight of 2% (wt/vol) Evans blue dissolved in saline (Fig. 2a,b and Supplementary Video 1). 
o CRITICAL STEP: the Evans blue injection is successful if the animal gets immediately bluish. 
This can be particularly well monitored at the paws, snout or tail of the animal (Fig. 2c and 
Supplementary Video 1) 
o CRITICAL STEP: Push the needle fast into the animal. Do not worry that you push it too deep 
because in this case it is no problem to retract the needle slightly. Use each needle only once as 
they should be sharp. If you fail to hit the heart the first time retract the needle completely and 
try once more.  
 
Dissection of the brain (day 1) TIMING ~5 min per animal 
3. Decapitate the perfused animal with a scissor and dissect the brain out of the skull using a fine scissor and a 
forceps. Carefully incise the skull at its lateral sides, starting posterior (cerebellum) all the way to anterior 
(bulbus olfactorius), on both sides of the skull (Fig. 2d and Supplementary Video 2).  
o CRITICAL STEP: Perform the skull dissection carefully by keeping the scissor blade that is 
located inside the scull away from the brain surface (Fig. 2d and Supplementary Video 2). 
Otherwise, this may cause damage to the brain tissue. 
4. Remove the skull from the brain tissue by pulling gently away using a forceps (Fig. 2e and Supplementary 
Video 2). Separate the brain from the inferior part of the skull by cutting the optic and other nerves using a 
forceps in order to facilitate brain tissue removal (Fig. 2f). 
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o CRITICAL STEP: Prevent tension on the brain tissue while removing the skull from the brain. 
Pay attention to also remove residual tissue of the dura mater (Fig. 2e and Supplementary 
Video 2). 
5. Cut the isolated brain into three coronal pieces e.g., according to the lines shown in Fig. 2g using a sharp 
scalpel or razor blade (Fig. 2h), in order to facilitate fixation.  
o CRITICAL STEP: brain regions which will be dedicated for stereological analysis should be 
kept intact 
6. If the experiment requires genotyping of the litter, keep a piece of the animal tail for genomic DNA 
isolation. 
 
Immersion fixation of the brain tissue (day 1) TIMING ~over night 
7. Transfer the isolated coronal brain pieces (Fig. 2h) immediately into 15ml of freshly prepared, cold 4% 
(wt/vol) FA + 0.025% (vol/vol) or 4% (wt/vol) FA + GA/0.05% (vol/vol) GA on ice. Place only one brain 
into 15 ml fixative. 
o CRITICAL STEP: Do not allow the brain tissue to dry out. Thus, transfer it to the fixative 
immediately. Use plenty of fixative (e.g. 15 ml per mouse brain as suggested here) in order to 
improve fixation. 
o CRITICAL STEP: For all antibodies mentioned in this protocol (Table 2 antibodies), freshly 
prepared or freshly thawed fixative containing 4% FA and 0.025% GA or 4% FA and 0.05% GA is 
a suitable fixative. Other antibodies may require alternative fixation protocols. 
8. Fix the samples overnight at 4°C and proceed to the cryoprotection 
 
Cryoprotection of the brain tissue (days 2-3) TIMING ~1-2 days 
9. Remove fixative and add 15ml freshly prepared, cold 30% (wt/vol) sucrose in 0.1M PBS to the brain tissue 
(coronal brain sections). Place the brain sections in a fridge at 4°C and store them for 2-3 days. 
10. After 2-3 days (when the brain samples have sunk to the bottom of the 15ml falcon tube), remove the excess 
of sucrose from the sample by gently touching the surface of the brain with a filter paper. 
o CRITICAL STEP: Do not allow the brain tissue to dry out. Thus, the transfer from the 30% sucrose 
to the Tissue Tek has to be quick. 
11. Put the coronal brain piece to a small aluminum foil container plastic mold filled with Tissue Tek and label 
the rostral and the dorsal parts. 
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o CRITICAL STEP: The orientation of the brain tissue is crucial for finding later the desired brain 
structures. Pay attention to correctly align the brain tissue in a rostral to dorsal manner. 
12. Put the coronal brain piece in Tissue Tek to 2-methylbutane at a temperature of -40°C. Remove the brain 
sample of the 2-methylbutane and immediately label the sample.  Put all samples of them into a plastic bag 
labeled with the animals name, and put this plastic bag on dry ice 
o CRITICAL STEP the temperature of the N-methylbuthane should be precisely -40°C (max. +/- 2°C) 
as guarantees an optimal and homogeneous freezing of the samples without tissue cracking. . 
o CRITICAL STEP: these steps have to be quick as temperature changes can alter the quality of the 
brain tissue 
13. If you plan sectioning the brain not instantly but within the next 1-3 days, store the tissue at -20°C. If longer 
storage is desired, keep the brain tissue at -80°C. 
o PAUSEPOINT: In our experience, storing the brain tissue at -80°C is superior to storing the brain 
tissue at -20°C. At -80°C, brain tissue can be stored without quality loss more than one year. 
However, put the brain tissue from -80°C to -20°C prior to cutting (otherwise, the brain tissue is to 
fragile/brittle for cutting; see below). 
 
Cutting of the brain tissue (starting on day 3-5) TIMING ~1 hour per animal  
14. If you stored the brain tissue at -80°C put it 2-4h prior to cutting brain sections to -20°C (either in the 
cryostat or a -20°C freezer) 
! CRITICAL STEP: If the tissue is too cold the sections will crumble while cutting. 
15. Within the cryostat, remove the brain tissue from the aluminum foil container or plastic mold used for 
freezing and mount it in a rostral to dorsal orientation using Tissue Tek.  
16. Adjust the temperature settings of the cryostat (tissue block: -20°C, knife/cryostat chamber: -20°C) 
17. Cut the brain tissue into 40 !m thick coronal sections and transfer them with a brush into a well of the 24 
well plate filled with 0.1M PB at room temperature (free floating sections), for orientation to the desired 
brain structures, we suggest the sources listed in Table 1. 
! CRITICAL STEP: 40 !m thick sections constitute an optimal sections thickness to assure both 
the 3D visualization of endothelial tip cell filopodia as well as an adequate antibody 
penetration. After being transferred to 0.1M PB, the sections should flatten out/deroll and not 
fall apart in the 0.1M PB 
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Table 1: Developing mouse Allen Brain Atlas (P4 and P7) 
 
Developmental 
stage, stain and 
cutting plane 
Web-link 
P4, overview  http://atlas.brain-
map.org/atlas#atlas=181276162&plate=100711203&structure=16382&x=4840&y=3720&zoom=-5&z=3 
P4, NISSL, 
sagittal 
!""#$%%&'(')*#+,-.*/0'1234+,5.4#1*3-%'6#'3+.',"%"!/.2,4+)0%788899:;<=+.4-'>"?#'@,+00) 
P4, NISSL, 
coronal 
!""#$%%&'(')*#+,-.*/0'1234+,5.4#1*3-%'6#'3+.',"%"!/.2,4+)0%78889A;;B=+.4-'>"?#'@,+00) 
P7, NISSL, 
sagittal 
!""#$%%&'(')*#+,-.*/0'1234+,5.4#1*3-%'6#'3+.',"%"!/.2,4+)0%7888C9C;8=+.4-'>"?#'@,+00) 
P7, NISSL, 
coronal 
!""#$%%&'(')*#+,-.*/0'1234+,5.4#1*3-%'6#'3+.',"%"!/.2,4+)0%7888;B89;=+.4-'>"?#'@,+00) 
 
 
18. Collect the 40 !m coronal sections in a 24 well plate filled with 0.1M PB (0.5 ml -1 ml per well)  
 
Staining procedure (starting on day 6) TIMING ~5 days 
19. Remove the 0.1M PB from the 24 well plates using a pipette. 
20. Postfix the P4 or P8 40-µm coronal free-floating sections for 10 min in either 4% (wt/vol) FA in 0.1M PB 
(P8 animals) or in 4% (wt/vol) FA, 0.05% GA in 0.1M PBS (P4 animals) (0.5 ml – 1 ml per well) depending 
on the desired antibody staining.  
! CRITICAL STEP: For maintaining the EB in place, GA added to the FA appears to be superior 
(Supplementary Fig. S3). Moreover, addition of 0.05% GA to the P4 coronal brain tissue sections 
ensures the stability of the brain tissue at this younger age 
21. Start antigen retrieval by incubating the sections in 50 mM NH4Cl in 0.1 M phosphate buffer for 30 min 
with gentle shaking (100 rpm) on an table (at room temperature). 
22.  
 Incubate the sections in 50 mM glycine in 0.1 M Tris (pH 8.0) for 5 min with gentle agitation on a tilting 
table at 80 °C 
23. Perform microwave heating (600 W) in CaCl2-containing buffer [0.1mM CaCl2 0.1mM MgCl2 0.1mM 
MnCl diluted in 0.1MPBS (pH 6.8), slightly modified according to53] for 30s up to 1.5 min.  
o CRITICAL STEP: antigen retrieval (and unmasking using microwave heating in particular) 
assures in our hands a better detection of endothelial tip cell (filopodia) 
24. Permeabilize the sections in 0.1 M Tris-buffered saline. 0.3% Triton X-100 for 10 min with gentle shaking 
on a table at room temperature. 
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25. Incubate the sections for 72h with gentle shaking on an inclined table at 4°C in primary antibodies diluted in 
CaCl2-containing buffer and blocking solution (0.05% Triton X-100 and 2% (vol/vol) normal goat serum 
(NGS) in 0.1M PBS) using primary antibodies or biotinylated IB4 (Table 2), respectively. The best 
alternative is excess normal serum from the species in which the secondary antibodies were raised. 
26. Thoroughly wash the sections three times in 0.1M PB/0.1M PBS for 5-10 min each with gentle shaking on 
an inclined table at room temperature 
27. Incubate the sections with gentle shaking on an inclined table overnight at 4°C in secondary antibodies 
diluted in CaCl2-containing buffer and blocking solution (0.05% Triton X-100 and 2% (vol/vol) normal 
goat serum (NGS) in 0.1M PBS) 
28. Thoroughly wash the sections three times in 0.1M PB/PBS for 5-10 min each with gentle shaking on a 
tilting table at room temperature 
29. Mount the sections onto labeled glass slides. Transfer the sections one by one to a dish with clean 0.1M PBS 
using a brush. Within this PBS-containing dish, carefully transfer the free floating coronal sections onto a 
clear glass slide 
! CRITICAL STEP: Perform this step with the glass slide submerged at half in a 0.1M PBS-
containing dish to prevent surface tension from rupturing the sections. This is – due to the fragility 
of the tissue - particularly relevant for mounting sections of mice at ages of P4 and P8 (less crucial 
for coronal sections of adult mice) 
30. Do not submerge the already mounted coronal sections into PBS, as they will detach again otherwise. Mount 
3-5 (ideally: 4) coronal sections onto a clear glass slide using MOWIOL mounting medium. Add a coverslip 
on top of the sections, remove the residual liquid on the edges of the cover slip using a tissue (Kleenex) and 
seal the coverslip using Nail Polish. Store the slides in dark at 4°C. 
 
Imaging (day 10-12) TIMING ~variable (entire confocal stacks, endothelial tip cells etc.) 
31. Identify the region of interest (for more detailed information, see paragraph “Cutting of the brain tissue”) 
32. Image the fluorescently labeled coronal brain sections using a confocal laser scanning microscope (e.g. in 
our case, we were using (SP5 and SP8, Leica Confocal Microscopes and a OLYMPUS Fluoview 1000 
Confocal Microscope)  
o CRITICAL STEP: For low magnification images and reference images use low NA objectives as 
10x. For the tip cells and filopodia we were using 63x NA1.4 or similar objectives.  
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Quantitative 3D analysis (day 10-12) TIMING ~variable (depending on the parameters to 
analyse - entire confocal stacks, endothelial tip cells etc.) 
33. Quantitative 3D analysis consists of two parts:  
Characterisation of the blood vessel network (stereological analysis,), see step 34, options A-E, and Figure 
5) and Characterisation of endothelial tip cells and their filopodia (isosurface generation, , filament tracing,see 
step 35, options A,B, and Figure 6)  
 
Characterisation of the blood vessel network - Stereological analysis TIMING 4h per mouse 
34. Assess vascular features quantitatively by their interaction with geometrical probes, i.e. points for vascular 
volumes, areas for vascular lengths and volumes for vascular branch points36,41. Use design-based 
stereological methods because the resulting estimates are unbiased in the sense that the number of 
interactions is independent of the size, shape or orientation of vascular features other than that of the feature 
of interest74. 
! CRITICAL STEP: The Region of Interest (ROI) was defined to comprise a complete cortical 
transect from the pial surface to the deep border of layer VI of a 40!m thick coronal brain section 
of a P8 mouse that was perfused with Evans blue (EB) and stained with biotinylated Isolectin B4 
(biotinylated IB4) (see Fig. 5a-f). StereoInvestigator 10 (MBF Bioscience, Williston, VT)was used 
to apply the probes to the confocal image stacks. Sampling was uniform random systematic. 
! CRITICAL STEP: Sampling parameters depend on both the size of the ROI and the densities of 
vascular features. They can be adjusted following the principles outlined by33,75-79. We recommend 
choosing parameters, as we did it here to provide approximately 100 sampling sites within the area 
of the image stacks and an average of 1-3 probe/feature interactions per probe. For data 
presentation, extrapolate all estimates to a volume of one cubic millimeter (Fig. 5j-n). 
 
Depending on the user’s interest, follow option A for vessel volume fraction, option B for vessel length, option C 
for vessel branchpoints, option D for vascular endothelial tip cells and option E for derived vascular 
parameters/values. 
 
 
(A) Vessel volume fraction 
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To estimate the volume fraction occupied by all vessels and by perfused vessels use the Area Fraction 
Fractionator80,81 (Fig. 5d,g). Here estimates were performed on randomly selected single optical planes (0.2!m 
thick) from confocal z-stacks to minimize over-projection errors. We used one plane of each stack. 
(i) Superimpose a 100 % 100 !m lattice of points spaced 8 !m apart to the ROI in this plane at sampling 
locations separated by 200 !m along the x- and y-axis (Fig. 5d,g). 
(ii) If a point (of the above-mentioned lattice) fell onto an IB4+ vessel structure (morphologically excluding 
IB4+/Iba1+ microglia structures (Fig. 5g, left side), next assess the Evan’s blue (EB) channel (Fig. 5g, right 
side). If the vessel structure was IB4+/EB+ (IB4/EB double-positive), count the point as perfused vessel 
volume; if the vessel structure was only IB4+, count  the point as non-perfused vessel volume (Fig. 5g). Base 
all volume estimates on the appearance of the vessel in the IB4 channel. Count all other points of the lattice 
and within the ROI as reference volume.  
(B) Vessel length 
To estimate total and perfused vessel length, use spaceballs36, i.e. isotropic surfaces in the form of hemispheres 
(Fig. 5e,h). We recommend the following substeps: 
(i) Generate hemispheres with a radius of 20 !m within the ROI of the image stacks at sampling locations 
separated by 70 !m along the x- and y-axis (Fig, 5h). 
(ii) Assess each crossing of an IB4+ vessel and the circles representing the circumferences of a hemisphere 
(Fig. 5h, left side) in the Evan’s blue channel (Fig. 5h, right side). Counting crossings as belonging to 
perfused or non-perfused vessel length according to the (ii) criteria in point 32. If a IB4+ vessel structure or a 
EB+ vessel structure was out of focus, the intersection was not counted (Fig. 5h, lower row). 
(C) Vascular branch points 
To estimate the number of vascular branch points for all and perfused vessels, use the Optical Fractionator74 
(Fig. 5f,i, upper row). To this end: 
(i) Place optical dissector samples sized 100 % 100 % 20 !m within the ROI of the image stacks at sampling 
locations separated by 150 !m along the x- and y-axis (Fig. 5i, upper row). 
(ii) Categorize branch points according to the number of vascular branches that originate from them and 
count separately. We only observed branch points comprising either 3 or 4 branches. 
(iii) Assess each branch point of an IB4+ vessel (Fig. 5i, upper row, left side) in the Evan’s blue channel 
(Fig. 5i, upper row, right side). Count vascular branch points as belonging to perfused or non-perfused 
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vessel length according to the criteria (ii)  . If a IB4+ vessel structure or a EB+ vessel structure is out of 
focus, do not count the intersection (Fig. 5h, lower row). 
(D) Vascular endothelial tip cells 
The Optical Fractionator74 should also be used to estimate the number of vascular endothelial tip cells (Fig. 5i, 
lower row). To this end: 
(i) Place optical dissector samples sized 100 % 100 % 20 !m within the ROI of the image stacks at sampling 
locations separated by 150 !m along the x- and y-axis. .(Fig. 5i, upper row) 
(ii) Define IB4+ endothelial tip cell cells as following: IB4+ vessel structures with a clearly defined tip cell 
body, from which a filopodia tree containing numerous filopodia emerge (Fig. 5i, lower row, left side; see 
also Fig. 4 and Fig. 6). As endothelial tip cell filopodia are not visible in the Evan’s blue channel (Fig. 5i, 
lower row, right side), endothelial tip cells cannot be addressed in the Evans blue channel. If an IB4+ vessel 
structure is out of focus, the intersection should not be counted (Fig. 5h, lower row). 
(E) Derived vascular parameters/values 
i) If desired, calculatee derived vascular parameters/values such as average diffusion distances, average 
capillary segment number, average capillary segment length and average capillary segment radius. These 
calculations are implemented in the software used (Stereoinvestigator) according to the formulas provided 
in41 (Fig. 5g, lower row). 
 
Characterisation of endothelial tip cells and their filopodia - Isosurface generation and filament tracing 
TIMING 30 min per endothelial tip cell 
35. Perform quantitative analysis of endothelial tip cell filopodia using Imaris software and the filament tracing 
module therein. Further qualitative morphological information is obtained by rendering the fluorescence 
signal of blood vessels to generate isosurfaces. The resulting isosurfaces allow to better distinguish the body 
of the vessel sprout from the endothelial tip cell filopodia. 
Follow option A for isosurface generation and option B for filament tracing. 
 
(A) Isosurface generation 
To generate isosurfaces, use the “surface” function in Imaris. 
(i) Identify the area of interest (e.g. cerebral cortex, hippocampus, etc.). 
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(ii) Identify endothelial tip cells in the sample using the microscope using a high NA objective (e.g. 63x, 
NA.1.4). 
(iii) Acquire image stacks of endothelial tip cells using an image format of 1024 x1024 pixels. Voxel size: 
80 x 80 x 170 nm. Use a sequential scan to detect the nuclei stained with DAPI using a 405 nm laser, for 
IB4 use a 561 nm laser and for Evans blue use a 633 nm laser. We set the detectors between 417- 476 nm, 
568 - 674 nm, and 641- 747 nm respectively. We used HyD detector (Leica) at 12 bit. 
(iv) Open the image stacks with Imaris and use the “surface” function to generate rendered volumes of the 
blood vessels. Select the “source channel” from which the surfaces are to be processed (e.g. the “EB 
channel” for perfused blood vessels or the “IB4 channel” for the entire vessel network). Check the “smooth” 
option to apply a Gaussian filter to the dataset and select a Surface area detail level. Large values will 
generate smoother and less detailed surfaces, the value should fit the detail level of the fluorescent structure.  
(v) Perform a “background substraction” to estimate the background intensity value of each voxel. 
Isosurfaces are generated according to a certain “threshold intensity level”. The “manual thresholding” 
allows a fitting of the isosurface to the fluorescent data.  
(vi) Control the generated isosurfaces using filters.  There are many filters, but “volume” and “intensity” are 
the most useful ones. The “volume filter” filters out too small or too large false volumes and the “intensity 
filter” can separate isosurfaces by their intensity values. 
(vii) The rendered isosurface volumes facilitate the filopodia tracing as the starting point of endothelial tip 
cell filopodia can better be defined.  
 
(B) Filament tracing (filopodia analysis) 
The filopodia analysis includes the analysis of filopodia number, filopodia length and filopodia 
tortuosity/straightness. To analyse filopodia, use the “filament” function in Imaris.  
(i) Identify the area of interest (e.g. cerebral cortex, hippocampus, etc.). 
(ii) Identify endothelial tip cells in the sample using the microscope using a high NA objective (e.g. 63x, 
NA.1.4). 
(iii) Acquire image stacks of endothelial tip cells using an image format of 1024 x1024 pixels. Voxel size: 
80 x 80 x 170 nm. Use a sequential scan to detect the nuclei stained with DAPI using a 405 nm laser, for 
IB4 use a 561 nm laser and for Evans blue use a 633 nm laser. We set the detectors between 417- 476 nm, 
568 - 674 nm, and 641- 747 nm respectively. We used HyD detector (Leica) at 12 bit. 
39 
 
(iv) Open the image stacks with Imaris (Bitplane) and use the “filament” function to trace the filopodia. We 
have used the autopath function to trace the filopodia. Alternatively, the software provides a manual and a 
more automatic function as well. We recommend the autopath function as a compromise between the fully 
automatic and the fully manual functions. In this mode, the origin of the filopodium is selected with a mouse 
click. Then, the filopodium can be traced by moving the mouse to the end of this filopodium, The software 
shows the trace of that particular filopodium in 3D. In this way, all visible filopodia emerging from one 
endothelial tip cell can be identified. 
! CRITICAL STEP: Whereas a fully automatic function is prone to errors due to the overlapping 
filopodia, a fully manual function, on the other hand, is very time consuming. The autopath 
function is a compromise between these two options: the researcher identifies the origin of the 
filopodia and the software provides a preview tracing along the volume of fluorescence filament 
candidates. Then, the researcher confirms the pre-traced filopodia by examination in fully 3D 
mode. Using the autopath function, it can be assured that the filopodia tracing is correct and 
feasible within a realistic time frame. 
(v) From Imaris, obtain filopodia number, filopodia length and filopodia tortuosity/straightness values from 
the traced filaments. 
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Table 2: Troubleshooting 
 
Step Problem Possible reasons Possible solution 
1-2 Air bubbles in the 
Evans blue that can 
kill the animal (due to 
air embolism) 
Air was aspirated into 
the syringe while 
filling it with EB. Air 
bubbles are difficult to 
see in the EB solution 
Look under the light, very 
precisely and remove any air 
bubble from the syringe. 
1-2 Animal does not 
become immediately 
blueD
Evans blue was not 
injected intracardiallyD
Pushing the needle too slowly into 
the animal results in failure to 
puncture the heart. If the needle is 
pushed too deep and the mouse 
does not get blue when starting the 
injection retract the needle slightly 
to re-enter the ventricle and inject 
the remaining EB. Alternatively, 
retract the needle completely and 
try once more. Always use for each 
puncturing attempt a new needle as 
it must be really sharp.   
Better solution: Inject a new 
animal because paracardial 
injection (failed injection) might 
disturb the animal’s circulation, 
and thus could result in a falsely 
high portion of non-perfused 
capillaries. 
1-2 Animal gets too blue 
(Evans blue diffuses 
into the brain 
parenchyma) 
Too much Evans blue 
was injected 
Animal has to be excluded 
Inject a new animal. 
Adjust the amount of Evans blue 
exactly to 6 !l/g body weight 
(rather a little bit less than too 
much) 
 
 
16-17 During cutting of brain 
sections, the brain 
tissue crumblesD
Temperature of knife 
and/or tissue block is 
too lowD
One day before cutting, put the 
frozen sections from -80°C to -
20°C 
Increase the temperature of the 
knife and of the tissue blockD
16-17 During cutting of brain 
sections, sections do 
not deroll in the PB 
Temperature of knife 
and/or of tissue block 
is too high 
if sections do not deroll, put 
sections in 0.1M PBS onto a shaker 
until they deroll at room 
temperature.  
Decrease the temperature of the 
knife and of the tissue block 
7-8 
 
 
19-26 
 
 
Weak Evans blue 
staining 
Poor antigeneicity 
 
 
Suboptimal fixation 
 
 
 
 
Use freshly prepared fixative 
solutions (4% (wt/vol) 
formaldehyde (FA) solution + 
0.025%/0.05% glutaraldehyde 
(GA) solution) 
After Evans blue perfusion, fix the 
brains in 4% FA + 0.025% GA or 
in or in % FA + 0.05% GA over 
night at 4°C 
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D
  
 
 
 
 
Cryoprotect the brains for 2-3 days 
in 30% sucrose at 4°C 
optimize antibody concentration; 
test alternative antibodies 
 
 
  
 
8, 20 
 
 
 
Endothelial tip cells 
(and/or filopodia) not 
clearly visible 
Fixation or 
postfixation too long 
 
 
 
Exclude the section from the 
analysis 
 
 
 
    
23-26 Weak antibody 
staining 
Suboptimal antibody 
concentration 
 
Insufficient tissue 
penetration of 
antibodies 
Optimize the concentrations for the 
first- and second antibodies; 
optionally, use fresh antibody 
batches or test antibodies from 
other manufacturers.  
Adapt the incubation time of the 
antibodies; use higher amounts of 
Triton-X 
27-28 Air bubbles in 
mounted sections 
 
Trapping of air 
bubbles during 
coverslipping 
Carefully lower the coverslip onto 
the section to avoid trapping of air 
bubbles 
 
26, 28 
 
 
 
High background 
staining 
Insufficient washing 
after antibody 
incubation 
 
 
Increase the frequency (not the 
duration) of the PBS-washes after 
and between antibody incubation 
steps 
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ANTICIPATED RESULTS 
With the technique described here, perfused blood vessels, the non-perfused segments of new 
vessels (e.g. vessel sprouts), the total vascular network, the number of endothelial tip cells as 
well as the number of filopodia per tip cell can be quantitatively assessed in the postnatal 
mouse brain. Blood vessels and endothelial tip cells extending numerous (Fig. 6q,t) filopodia 
were visualized in different brain regions of postnatal day 8 (P8) mouse brain sections using 
IB4 staining (Fig. 3b-f). Endothelial tip cells were found in various brain regions including 
cortex, hippocampus and corpus callosum (Fig. 3c-f), indicating active sprouting angiogenesis 
at this stage of mouse development. IB4 also labels microglia/macrophages (Fig. 3g-j), as 
described earlier54,55. Therefore we recommend a double labeling with IB4 and a 
microglial/macrophage marker such as Iba1 to distinguish IB4+/Iba1- endothelial cells from 
IB4+/Iba1+ microglia/macrophages (Fig. 3g-j). In our hands, this staining protocol identifies 
tip cells better than the suggested tip cell markers VEGFR2, VEGFR3 or Dll424,63,64 
(Supplementary Fig. S2a-l). One reason may be that Dll4, VEGFR2, and VEGFR3 are 
internalized and thus less abundant at the cell surface, as previously shown for VEGFR282-86 
and for VEGFR387. Moreover, as there is still no specific endothelial tip cell marker, 
morphological features are crucially needed in order to identify this specific cell type 
appropriately. 
Functional, perfused blood vessels can be best visualized with a marker that is injected into 
the circulation of an intact, living animal. To this end, we used Evans blue (EB) that labels the 
vascular lumen of actively, in vivo perfused blood vessels. Thus, EB+/IB4+- perfused vessels 
can be distinguished from IB4+ but EB- forming blood vessels that are not yet 
functional/perfused (Fig. 4a-c, Fig. 6, Supplementary Fig. S1) and from endothelial tip cells 
(Fig. 4d-f, Fig. 6, Supplementary Fig. S1). The basement membrane - visualized by Laminin 
(LN) – was  present around perfused blood vessels but only partially at the tip cell body (Fig. 
4g-k,m, Fig. 6l,p), allowing further differentiation of various steps in blood vessel maturation. 
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Endothelial tip filopodia were quantified by filament tracing in Imaris (Fig. 4d-f,l, Fig. 6h,q-t 
Box 1). Vessel parameters such as vessel volume fraction, vascular length and number of 
branch points of EB+/IB4+ perfused vessels and EB-/IB4+ sprouting vessels as well as the 
tissue volume density of IB4+ endothelial tip cells can be quantified using a stereological 
method adapted from36,41 (Fig. 5a-n, Box 2). For quantitative assessment of angiogenic 
features such as vessel volume fraction, vessel length, vascular branch points and endothelial 
tip cells, we recommend to track all counted structures using markers provided by all 
stereological software packages (Fig.5d-i, Box 2). Examples of quantification of the 
aforementioned vessel parameters in the postnatal mouse cortex are displayed in Fig. 5j-n. 
Stereological analysis revealed that 3.86% of the total volume of the postnatal mouse brain 
tissue was occupied by vessel structures (perfused or non-perfused), which is in accordance 
with previous findings88,89. Of the total vessel tissue volume, 3.58% (92.75% of the total 
vessel volume) were occupied by perfused vessels and 0.28% (7.25% of the total vessel 
volume) by non-perfused vessels (Fig. 5j). This corresponds to a total of 2782 capillaries 
(capillary segments from branchpoint to branchpoint) per mm3 of postnatal mouse brain tissue 
of which 2034 capillaries/mm3 were perfused and 748 capillaries/mm3 were non-perfused, 
respectively. In one mm3 of postnatal mouse brain tissue, the total length of vessel structures 
was 904 mm, of which 830 mm were perfused and 74 mm were not perfused (Fig. 5k). 
Furthermore, our analysis revealed 4918 branchpoints of valence 3 (3 vessel branches 
emanating from the vessel branch point) per mm3 (3635 perfused and 1283 non-perfused), 
321 branchpoints of valence 4 (4 vessel branches emanating from the vessel branchpoint) per 
mm3 (214 perfused and 107 non-perfused) (Fig. 5l,m) and 2028 endothelial tip cells per mm3 
(Fig. 5n). 
Endothelial tip cell filopodia can only be recognized in the IB4 but not in the EB channel 
(Fig. 5i lower row). In addition to these measured values, further values such as the number of 
capillaries (total: 2782 capillaries/mm3, perfused: 2034 capillaries/mm3, non-perfused: 748 
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capillaries/mm3), the average capillary length (325 !m), average capillary radius (2.7 !m) and 
the average maximal perfusion distance (19.6 !m) can be derived (Fig. 5g lower row). Given 
the high angiogenic activity in the postnatal rodent brain11, it is obvious that the precise values 
of the aforementioned parameters will vary depending on the exact developmental stage of the 
animal. 
The combination of EB perfusion and IB4- and LN immunofluorescence can be used to 
further characterize endothelial tip cells (Fig. 6). We observed two groups of filopodia-
extending endothelial cells: the first group at the leading edge of the vascular sprout 
(extending numerous (around 23 per cell), longer filopodia; classified as “endothelial tip 
cells”), and the second group along the body of the vessel sprout (extending fewer (around 8 
per cell), shorter filopodia; classified as “endothelial cells with filopodia”) (Fig. 6a-p,q,r,t). 
Whereas the number of filopodia per cell and the filopodia length varied significantly between 
these two groups, the filopodia straightness did not (Fig. 6s,t). These values might vary in 
different experimental settings and thus correlate with the angiogenic activity of the 
investigated tissue24. However, it is important to state that these specifications of single 
endothelial cells at a given time point may rapidly change as the tip vs. stalk cell phenotypes 
were shown to be transient66. Nevertheless, we feel that the filopodia density per tip cell as 
well as the average length of the filopodia obtained from a larger cell population might be 
helpful readouts for better understanding angiogenesis in various biological settings. 
In the CNS, the neurovascular unit involves multiple cell types such as astrocytes, pericytes, 
neurons and microglia that are recruited subsequently to the forming vessels7 and are 
necessary for the proper function of the CNS vasculature8,90,91. Our protocol allows 
simultaneous visualization and analysis of these perivascular cells (Supplementary Fig. S3 
and Table 2 antibodies). For example, GFAP+ astrocytes form astrocytic endfeet on the 
basement membrane enclosing both, the endothelium and the pericyte (Supplementary Fig. 
S3a-d). At P8, retracting radial glia is also GFAP+ (Supplementary Fig. S3a,b,d), in 
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accordance with previous reports12. PDGFR"+ pericytes (Supplementary Fig. S3e-h) stabilize 
the endothelium and the two cell types are embedded in a common basement membrane 
(Supplementary Fig. S3i-l). Neuronal cell protrusions, for instance Nf160+ axons in the corpus 
callosum, can also be visualized (Supplementary Fig. S3m-p). Of note, as virtually any 
antibody of interest can be used in our protocol, it is for example also possible to further 
distinguish arteries/arterioles from veins/venules although we do not describe how to do this. 
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Table 3: Examples of markers and antibodies for endothelial cells, perfused vessels and perivascular cell types of 
the neurovascular unit 
 
Cell type/  
Vascular structure 
Marker/Primary 
antibody 
Secondary antibody/ 
Detection system 
Important remarks 
Endothelial phalanx 
-stalk, and -tip cell 
(filopodia) 
Biotinylated IB4 
(Sigma, L 2140), 
diluted 1:50 in 
CaCl2-containing 
buffer 
 
 
 
 
 
 
 
 
Rabbit anti-
VEGFR2 antibody 
(Cell Signaling, cat. 
no. 2479), diluted 
1:1,000 in CaCl2-
containing buffer 
Goat anti-VEGFR3 
antibody (R&D 
Systems, cat. no. 
AF743) diluted 
1:1,000 in CaCl2-
containing buffer 
Rabbit anti-Dll4 
antibody (R&D 
Systems, cat. no. 
MAB1389) diluted 
1:1,000 in CaCl2-
containing buffer 
 
Streptavidin-Cy3 (green, 
Ex: 550nm; Em: 570nm), 
Streptadivin-Alexa Fluor 
543 (red), Strepdavidin-
Dye-light 647 (red), all 
1:500 in CaCl2-containing 
buffer 
Binds to sugar 
residues on the 
endothelium 
Marks established, 
perfused as well as 
newly forming blood 
vessels including 
endothelial tip cell 
filopodia 
Also marks 
microglia, 
macrophages 
 
Suggested 
endothelial tip cell 
markers that bind to 
surface receptors on 
the endothelium. 
All three markers 
preferentially label 
endothelial tip cell 
bodies but less 
intensively their 
filopodia. Moreover, 
they also label 
endothelial stalk- and 
phalanx cells. Thus, 
these markers label 
perfused as well as 
newly forming blood 
vessels 
Microglia Anti-rabbit Iba1 
Wako, Code NO. 
019-19741), diluted 
1 :200 in CaCl2-
containing buffer 
According to the 
combination with other 
markers/antibodies 
Binds to sugar 
residues 
Marks non-
activated/activated 
microglia 
Perfused vessels Evans blue (Dye 
content & 75%, 
Sigma, E2129), 
diluted in 0.9% 
NaCl 
Autofluorescent (far red, 
Ex.: 633 nm; Em.: 640 – 
700 nm) 
Binds to serum 
albumin 
Marks established, 
perfused blood 
vessels but newly 
forming blood 
vessels and 
endothelial tip cell 
(filopodia) 
Astrocytes Rabbit-anti GFAP 
(Dako, Z 0334), 
diluted 1 :1000 in 
According to the 
combination with other 
Binds to Glial 
fibrillary acidic 
protein (GFAP), 
which is the principal 
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CaCl2-containing 
buffer 
markers/antibodies intermediate filament 
of mature astrocytes 
Pericytes Rat-anti-mouse 
PDGFR" (CD140b) 
(eBioscience, 
12 1402), diluted 
1 :200 in CaCl2-
containing buffer 
According to the 
combination with other 
markers/antibodies 
Binds to CD140b 
molecule, the " chain 
of the platelet derived 
growth factor 
receptor (PDGF 
receptor) 
Neurons Rat-anti-mouse 
Nf160 Zymed,13-
0700), diluted 1: 250 
in CaCl2-containing 
buffer 
According to the 
combination with other 
markers/antibodies 
Binds to 
neurofilaments (Nf) 
in neurons 
Ex. : Excitation ;  Em. : Emission 
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FIGURE LEGENDS  
 
Figure 1 Flow chart, summary, and time frame of the protocol 
The different sections of the protocol are indicated in color-coded boxes. White boxes 
indicate preparation steps, green boxes describe experimental steps, blue boxes indicate 
analysis steps and brown boxes describe quality control steps. Black arrows indicate the order 
in which the different steps of the protocol are performed. The left side provides a time scale. 
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Figure 2 Intracardial Evans blue injection and brain dissection 
a,b Angles (a,b) and site (white arrowheads (b,c), ~1-2 mm below the horizontal line 
connecting both armpits; ~1-2 mm on the right side of the midline) for intracardial Evans blue 
injection in a P8 mouse pup (see also Supplementary Video 1). c Comparison between an 
animal before injection (left side) and after Evans-injection (right side). Successful perfusion 
is indicated by a bluish aspect of the animal, which can be well observed at the paws (right 
side, arrows), snout or tail. White arrowhead marks the injection site. d-f Dissection of a P8 
mouse brain (see also Supplementary Video 2). Position and stabilize the head between two 
fingers in a convenient orientation (d). Open the skull using a fine spring scissor starting at 
the foramen magnum (arrow in d) and cut the scull on both sides to the rostral end. Then lift 
up the scull (arrow in e) with the scissor or a forceps and verify that the meninges (including 
tentorium cerebelli) are removed completely. The brain is then carefully lifted caudally with a 
fine forceps that is also used to cut the brain nerves (e.g the trigeminal nerves, marked with 
arrows in f). g Comparison of a dissected Evans blue-injected P8 mouse brain (blue, top) and 
a non-injected P8 mouse brain (light red, bottom). The bluish appearance of the Evans blue 
injected mouse brain serves as a quality control (see Fig. 1). Dashed lines indicate planes 
where to cut the brain tissue. h Coronal slices of an Evans blue injected P8 mouse brain after 
cutting as indicated in g. Scale bars: 5 mm (g,h). 
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Figure 3 Visualization of blood vessel endothelium and endothelial tip cells in the 
postnatal mouse brain at P8 
a Schematic representation of postnatal mouse brain vascularization (red) on coronal brain 
sections. The selection of the brain regions analyzed here has been done on coronal sections 
in the structures selected using the Developing Mouse Allen Brain Atlas. A corresponding 
immunofluorescence image of the boxed area taken at low magnification is shown in b. b 
Overview of a 40 !m P8 coronal mouse brain section labeled with biotinylated IB4 to 
visualize vascular endothelial cells (red). Cell nuclei (DAPI, blue). c-f IB4+ endothelial tip 
cells extending multiple filopodia (red) in layer V (c) and in layer VI could be found in gray 
matter structures such as the cingulate cortex (c,d) or CA1 (e) of the hippocampus as well as 
in white matter structures such as the corpus callosum (f). Cell nuclei were counterstained 
with DAPI (blue). q-j Iba1 (green) and IB4 staining (red) in the P8 mouse cortex. Boxed area 
is enlarged in h-j. IB4 labels endothelial cells (including endothelial tip cells) but also 
microglia (g-i). IB4+ but Iba1- structures can be identified as endothelial cells (g,h) whereas 
IB4+ and Iba1+ structures are microglia (g-j). Cell nuclei were counterstained with DAPI 
(blue). 
Scale bars: 500 !m (b) ; 50 !m (g), 10 !m (c-f, h-j) 
SS = Sagittal sulcus; Ctx = Cortex ; CC = Corpus Callosum; CA 1 = Cornu Ammonis 1; CA 3 
= Cornu Ammonis 3; DG = Dentate Gyrus. 
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Figure 4 Discrimination between perfused blood vessels and newly forming sprouting 
blood vessels and endothelial tip cells in the P8 mouse cortex 
a-m Perfused and non-perfused blood vessels in P8 WT mouse cortex. a-c Confocal images 
of an EB-perfused P8 WT mouse cortex stained for IB4 to visualize blood vessel endothelial 
cells. IB4 (red) labels the endothelium of the entire vascular tree (a,c). Functional-perfused 
blood vessels are labeled with EB (b) and are EB+/IB4+ (c). In contrast, not yet perfused, 
newly forming blood vessels are EB-/IB4+ (c). The boxed area is enlarged in d-f. Arrowheads 
in (a,b) point to IB4+ but EB- vessels that are not perfused. .d Perfused vessels and vascular 
sprouts including endothelial tip cells are shown. White solid arrowheads indicate IB4+ but 
EB- endothelial tip cells extending multiple filopodia, thus, non-perfused not yet functional 
vascular structures. White arrow indicates a newly forming vascular sprout with its 
endothelial tip cell emanating from a functional EB+/IB4+ perfused blood vessel. White open 
arrowheads show EB+/IB4+ perfused blood vessels including endothelial stalk- and phalanx 
cells. e 3D rendering of the image shown in (d) generated with Imaris software (see Box 1) to 
separate blood vessels from microglia. IB4-labeled blood vessel structures are coded in 
yellow, EB-labeled blood vessel structures are coded in blue and microglia is displayed in red. 
(f) 3D rendering of data in (e) showing reconstructed IB4-labeled vessels using isosurfaces 
with subtracted background (no microglia visible). g-k 3D confocal stacks of a newly forming 
blood vessel that sprouts from a pre-existing blood vessel. IB4 (red) labels the entire vascular 
network including endothelial tip cell filopodia, Laminin (LN, green) marks the vascular 
basement membrane and EB (cyan) highlights the perfused vessel parts. LN+ structures 
(green) enclose EB+ vessel parts (cyan) and LN+ structures indicate at least partially matured 
vessel structures. DAPI-stained cell nuclei (blue). l Reconstruction of the vascular sprout and 
the endothelial tip cell displayed in g-k by Imaris software using isosurfaces (displayed in 
green) and filopodia tracing (displayed in red)  (see Box 1). m Scheme of the different 
structures of sprouting angiogenesis in the postnatal mouse brain and illustration how these 
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can be distinguished with our method. Sprouting blood vessels emanating from an established 
blood vessel are led by endothelial tip cells sensing the CNS-microenvironment for attractive 
and repulsive guidance cues using finger-like filopodia, thereby steering the growing blood 
vessels. Perfused blood vessels are EB+/IB4+, vascular sprouts are EB+/IB4+ or EB-/IB4+. The 
endothelial tip cell body and its filopodial tree are EB-/IB4+. LN indicates the vascular 
basement membrane. 
Scale bars: 100 !m (a-c) ; 50 !m (d-f) ; 10 !m (g-l)
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Figure 5 Stereological analysis of the vascular network in the P8 mouse cortex 
a-c Confocal images of a P8 mouse cortical brain section. Blood vessel endothelial cells are 
visualized using IB4 (a,c) and perfused vessels are highlighted by EB (b,c). Regions of 
interest (ROI) are indicated (white boxes). d-f Different probes in are used to quantify various 
aspects of the 3D vascular network, e.g. the area fractionator (displayed as white point grid 
squares) to quantify the vessel volume fraction (d), spaceballs (intersections are displayed as 
green dots) to quantify the vascular length (e) and the optical fractionator (counts are 
displayed as different symbols) to analyze the number of branchpoints and endothelial tip 
cells (f). These analyses are done for both channels, IB4 and EB (only IB4 is shown for the 
overviews (d-f)). The boxed areas are enlarged in (g-i). g-i Examples of how to analyze 
different parameters of the 3D vascular network in the P8 mouse cortex. Multiple point grid 
squares (100 !m x 100 !m) (see box 2) are randomly superimposed on the region of interest 
(ROI) within confocal images to analyze the vessel volume fraction (g). Grid points 
overlaying vessel structures are counted. White dots mark EB+/IB4+ perfused vessels whereas 
green dots mark EB-/IB4+ non-perfused forming blood vessels (g). Spaceballs (hemispheres) 
(see box 2) with a maximal diameter of 40 !m are randomly placed on the ROI within 
confocal images to analyze the vessel length. Intersections of vessel structures with the 
spaceball-surface are counted in the IB4- (left side) and in the EB channel (right side) and are 
marked by green dots (h). Note that intersections are only counted if they appear in focus 
(upper row), but not if they are out of focus (lower row) (h). Squares of 100 !m x 100 !m 
(for branchpoints, upper row) or of 150 !m x 150 !m (for endothelial tip cells, lower row) are 
randomly placed on the ROI within confocal images to analyze the number of branchpoints 
(upper row) or the number of endothelial tip cells (lower row). Branchpoints or endothelial tip 
cells within these frames are counted. Branchpoints or endothelial tip cells falling onto the 
green sides of the square (right and upper) are taken into account whereas branchpoints or 
endothelial tip cells falling onto the red sides of the square (left and lower) are not counted 
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(h). Branchpoints are analyzed in the IB4- (upper line, left side) and in the EB channel (upper 
line, right side). Branchpoints of valence 3 (3 vessel branches emanating from the vessel 
branchpoint) are marked with green stars and branchpoints of valence 4 (4 vessel branches 
emanating from the vessel branchpoint) are marked with white stars. Endothelial tip cells are 
analyzed in the IB4 channel (lower line, left side; marked with a double yellow circle) but do 
not appear in the EB channel (lower line, right side). Table shown in (g) summarizes 
measured and derived values for characterization of the vascular network. j-n Values of the 
different vessel parameters in the P8 mouse brain cortex as described above. Vessel volume 
fraction of perfused-, non-perfused- and total vessels (j). In a P8 mouse brain cortex, ~3.86% 
of the tissue is occupied by vessel structures, from which ~92.75% are perfused and ~7.25% 
are non-perfused (j). Length of perfused-, non-perfused- and total vessels (k). Number of 
branchpoints of valence 3 (l) and of valence 4 (m) of perfused-, non-perfused- and total 
vessels (l,m). Number of cortical endothelial tip cells (n). There are 2028 endothelial tip cells 
in a mm3 P8 mouse brain cortex. 
Scale bars: 200 !m (a-f), 50 !m (g-i). 
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Figure 6 Characterization of endothelial tip cells in the postnatal mouse brain at P8 
a,b Endothelial tip cell in the P8 mouse cortex, visualized by IB4-labeling (a). Note the well-
defined cell body, the numerous, finger-like filopodia extending from the tip cell body and the 
absence of EB labeling (a). Next to the endothelial tip cell, a EB+/IB4+ perfused blood vessel 
is visible (b). Cell nuclei (DAPI, blue). c,d Endothelial cell extending filopodia (c) on both 
sides of an EB+/IB4+ perfused blood vessel (d) in the P8 mouse cortex, visualized by IB4+. 
This endothelial cell extends few filopodia that are oriented ~90° to the axis of the blood 
vessel from which they emanate. Note the absence of a well-defined cell body (c). Cell nuclei 
(DAPI, blue). e-g Vascular sprout in the P8 mouse cortex. Two tip cells at the forefront of the 
vascular sprout and an endothelial cell extending filopodia in the body of the vascular sprout 
are shown. EB-/IB4+ filopodia and EB+/IB4+ perfused blood vessel are displayed. h 
Endothelial tip cells and endothelial cells with filopodia can be visualized using IMARIS 
software. Isosurfaces are used to visualize the body of the vessel sprout (green) and filopodia 
are traced using the filament tracer module in IMARIS (red) (see Box 1). Different structures 
of the vascular sprout are labeled. i-k Two IB4+ Endothelial tip cells extending numerous 
filopodia at the forefront of a vascular sprout in the P8 mouse cortex. Note that vascular 
sprout bodies are well developed and perfused, as highlighted by EB (i,j,k). The filopodial 
tree is well established (“finger- or hand-like”) and filopodia extend mainly in the axis of the 
EB-perfused vascular sprout body (i,j,k). l Part of vascular sprout behind the tip cell with a 
well-established, LN+ vascular basement membrane surrounding the EB+ perfused vessel 
lumen. m-p IB4+ endothelial cell extending few filopodia. A sprout body in the axis of the 
filopodia has not developed yet (m,n,o) and its filopodial tree is less well established with 
filopodia oriented mainly ~90° to the axis of the existing, EB-perfused vascular sprout  
(m,n,o). p Part of vascular sprout behind the tip cell. Note LN+ vascular basement membrane 
surrounding the EB+ perfused vessel lumen. q-s Comparison of different quantitative 
filopodia parameters between endothelial tip cells and endothelial cells extending filopodia. 
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The filopodia number per tip cell is ~3 times higher for endothelial tip cells as compared to 
endothelial cells extending filopodia (q). Moreover, endothelial tip cells extend 1.5 times 
longer filopodia than endothelial cells with filopodia (r). No major difference in filopodia 
straightness was found between endothelial tip cells and endothelial cells extending filopodia 
(s). t Table summarizing different typical features of tip cells and of endothelial cells 
extending filopodia. All data are shown as mean ± s.e.m. (n = 7-10). *P < 0.05, **P < 0.01, 
***P < 0.001. 
Scale bars: 10 !m (a-d); 20 !m (e-g); 10 !m (h), 10 !m (i-k) ; 5 !m (l); 5 !m (m-p). 
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SUPPLEMENTARY VIDEO LEGENDS 
 
Supplementary Video 1 Intracardial Evans blue injection of a P8 mouseThis video shows 
the different steps of intracardial Evans blue (EB) injection of a P8 mouse pub. All steps are 
precisely explained in the “PROCEDURE” part of this manuscript. 
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Supplementary Video 2 Brain dissection of a P8 mouse 
This video shows the different steps of brain dissection of an Evans-blue (EB) injected P8 
mouse pup. All steps are precisely explained in the “PROCEDURE” part of this manuscript. 
 
 
Immuno!uorescent stainings
with (biotinlyated) Isolectin B4
and with antibodies of interest
Steps 19-27
P0 = day of birth
Material preparation (Evans
blue, "xatives, sucrose)
Preparation steps
Quality control (Steps 9-11)
- under epi!uorescent micro-
scope1, vessels must be EB+ 
- Judgment of EB quality2,3
see also „TROUBLESHOOTING“
Quanti"cation using IMARIS and
stereoinvestigator, 3D vessel 
reconstruction; Steps 31-39
Key equipment needed: IMARIS-
and Stereoinvestigator programs
Figure 1
Imaging brain sections using
confocal microscopy, image ana-
lysis using IMARIS; Steps 28-29
Key equipment needed: confocal
microscope, IMARIS program
Brain dissection, Immersion-
"xation in 4% PFA + 0.025% -  or 
+ 0.05% GA in 0.1M PB over night
Steps 3-8 (Fig. 2d-h)
Cryoprotection in 30%
sucrose in 0.1M PB for 2-3 days
 
Step 9
Parameters:
- perfused vs. non-perfused vess.
- vessel volume fraction [/mm3]
- endothelial tip cells ("lopodia)
Steps ??-??
Day 1
Day 1-2
Day 2-3
Day 3-5
Day 6-10
Day 10-12
Day 10-12
Quality control (Step 2)
- immediately after EB injection,
the animal has to become bluish1
- Judgment of perfusion2,3,4
see also „TROUBLESHOOTING“ 
Experiment
Analysis
Preparation
Freezing in Tissue Tek 
Cryostate cutting (40 Pm free-
!oating brain sections), 
Steps 10-18
Key equipment needed: cryostate
Parameters:
- perfused vs. non-perfused vess.
- vessel volume fraction [%/mm3]
- vessel length [mm/mm3]
- vessel branchpoints, endothelial
tip cells [number/mm3]
- tip cell "lopodia ["lopodia num-
ber/tip cell]; ["lopodia length]
Steps 31-39
P4 or P8 mice (Steps 1-2, Fig. 2a-c)
Intracardial Evans blue injection
(6 Pl/g body weight of 2% Evans
blue in 0.9% NaCl, 30.5 G needle),
circulation time: 5-10 min 
1: for quality control, use brain tissue not needed
for the analysis, e.g. the most rostral part of
the EB-perfused brain (cf. Fig. 2h)
2: Adequate EB quality: EB in blood vessels and
capillaries clearly visible and with good contrast to the
surrounding brain parenchyma
--> include the animal into the analysis
3: Insu#cient EB quality: blood vessels and
capillaries not or barely visible, EB di$usion into
surrounding brain parenchyma
--> exclude the animal from the analysis
  
1: to be best controlled at the paws or at the tail
(cf. Fig. 2c)
2: 70-80% success rate depending on the experience
of the experimenter
3: successfull injection: tail and paws become
immediately bluish
--> include the animal into the analysis
4: injection failure: tail and paws stay pale
--> exclude the animal from the analysis
Quality control
cFigure 2
d
f
a b
e
ca. 30°
c
ca. 10°
g h
Figure 3
P8 Coronal sectionb
IB
4 
/ D
A
P
I  
b
CC
CC
CA1
CA3
SS
DG
Ctx
a
Ib
a1
 / 
IB
4 
/ D
A
P
I  
P8 Cortex - tip cellh P8 Cortex - tip celliP8 Cortex - tip cellg P8 Cortex - tip cellj
h-j
a
IB
4 
/ D
A
P
I  
P8 Cortex - layer 6d  P8 Hippocampus-CA1 eP8 Cortex - layer 5c P8 Corpus callosum f
Hippocampus
Selection of brain region according to
Developing Mouse Allen Brain Atlas
Corpus callosum
Ventricle
Cortex
a
Txema: very slight disturbances in the pictures (vertical and hori
zontal lines)
Txema: for d-f, I need the pictures with and without scale bars
--> I could not !nd them but think that we have done them
together...PLEASE tell me where they are located!
CAVE (Txema): the overview and this zoom
do NOT have the same orientation (see
rectangle in c) and compare with d))
disturbance disturbance disturbance
Figure 4
E
B
 / 
IB
4 
   
  
P8 Cortexa P8 Cortexb P8 Cortexc
a
 E
B
 / 
LN
 / 
IB
4 
  
P8 Cortex - tip cellh P8 Cortex - tip celliP8 Cortex- tip cellg P8 Cortex - tip cellj
E
B
 / 
LN
 / 
IB
4 
/ D
A
P
I 
P8 Cortex - tip cellk P8 Cortex - tip celll m
EB+/IB4+
perfused vessel
IB4+vascular sprout
and endothelial tip cell
LN+
basement membrane
disturbances
background white?
put IMARIS frame?
other colors?
d-f
d
f
e
jFigure 5
E
B
 / 
IB
4 
   
  
P8 Cortexa P8 Cortexb P8 Cortexc
with ROI from layer I-VI with ROI from layer I-VI
Lutz: Layers individually?
with ROI from layer I-VI
Lutz: Layers individually?
here: show examples of semispheres
E
B
 / 
IB
4 
   
  
Vessel volume fraction d Vessel lengthe Branchpointsf
with ROI and optical
fractionator
with ROI and optical
fractionator
with ROI and optical
fractionator
has to be CYAN
--> and rectangle thicker!
k l n
E
B
 / 
IB
4 
   
  
Vessel volume fractiong Vessel lengthh Branchpoints, tip cellsi
ZOOM ZOOM
scale bar scale bar scale bar scale bar
g
i
g
disturbance d
h
scale bar
disturbance
scale bar
disturbance
scale barscale bar
i
Vessel volume fraction
Measured values
Vessel length
Branchpoints valence 3
Branchpoints valence 4
Endothelial tip cells
Derived values
number of capillaries
average capillary length
average capillary radius
average max. perf. dist.
m
non
-pe
rfus
ed
per
fuse
d
tota
l
0
1
2
3
4
5
P8 Cortex
ve
ss
el
 v
ol
um
e 
fra
ct
io
n 
[%
]
non
-pe
rfus
ed
per
fuse
d
tota
l
0
200
400
600
800
1000
ve
ss
el
 le
ng
th
 [m
m
/m
m
3 ]
P8 Cortex
non
-pe
rfus
ed
per
fuse
d
tota
l
0
2000
4000
6000
br
an
ch
 p
oi
nt
s 
- v
al
. 3
 [n
um
be
r /
m
m
3 ] P8 Cortex
non
-pe
rfus
ed
per
fuse
d
tota
l
0
100
200
300
400
P8 Cortex
br
an
ch
 p
oi
nt
s 
- v
al
. 4
 [n
um
be
r /
m
m
3 ]
tota
l
0
500
1000
1500
2000
2500
P8 Cortex
E
nd
ot
he
lia
l t
ip
 c
el
ls
 [n
um
be
r /
m
m
3 ]
defect/brightness change
in the middle
--> need your HELP!
brightness
change
Txema: still small defect
in picture
zoom81
zoom87 (other initial
picture than above)
zoom155 (other initial
picture than above)
zoom155 (other initial
picture than above)
scheme established
tip cell
Figure 6
a
a
 E
B
 / 
IB
4 
  
P8 Cortex tip cellsf P8 Cortex tip cellsgP8 Cortex tip cellse h
a
 E
B
 / 
LN
 / 
IB
4 
  
P8 EC with filopodian P8 EC with filopodiaoP8 EC with filopodiam P8 EC with filopodiap
EB - LAM LAM - IB4 EB - IB4 ZOOM ON TIP 
CELL 3D SURPASS
HERE: EB-IB4
--> not EB-LN-IB4
 E
B
 / 
D
A
P
I /
 IB
4
P8 Tip cell P8 Tip cellb c P8 EC with filopodia P8 EC with filopodiad
established tip cell
a) IB4-DAPI
b) EB-DAPI
forming tip cell
c) IB4-DAPI
d) EB-DAPI
a
 E
B
 / 
LN
 / 
IB
4 
  
P8 Tip cellj P8 Tip cellkP8 Tip celli P8 Tip celll
EB - LAM LAM - IB4 EB - IB4 ZOOM ON TIP 
CELL 3D SURPASS
rq s
forming tip cell:
EB-IB4
forming tip cell:
EB-LN
forming tip cell:
LN-IB4
established tip cell:
IB4 two tip cells
established tip cell:
EB two tip cells
established tip cell:
EB-LN behind two tip
cells
t
defect/black line in
picture
defect/darker region
in picture
picture without scale
bar lacking!
defects in pictures (dark lines)
with/without scale bar
--> there was this problem
with the computer...
i-l
m-p
EC with filopodia Tip Cell
Leading edge
Body
filopodia tree
filopodia number
filopodia length
Criteria
not developed developed
not developed developed
~90° to vessel axis
~ 8 per tip cell ~ 23 per tip cell
~ 11 Pm ~ 17 Pm
perfusion1 no yes or no
EC
 wit
h fi
lop
.
Tip
 ce
ll
0
5
10
15
20
EC
 wit
h fi
lop
.
Tip
 ce
ll
0
10
20
30
0.0
0.2
0.4
0.6
0.8
1.0
along vessel axis
1perfusion of the vessel body behind the tip cell parallel 
to the axis of the main direction of the filopodia tree
fil
op
od
ia
 n
um
be
r /
 ti
p 
ce
ll
P8 Cortex
+ 189%
***
fil
op
od
ia
 le
ng
th
 [P
m
]
P8 Cortex
+ 50%
**
fil
op
od
ia
 s
tra
ig
ht
ne
ss
P8 Cortex
- 3%
n.s.
Leading edges
of vascular
sprout
Filopodia tree
Tip cell 
Body of
vascular
sprout
EC with filopodia 
EC
 wit
h fi
lop
.
Tip
 ce
ll
1 
 
Supplementary Figure S1 
Optimization of the tissue fixation protocol to combine EB-perfusion and IB4 endothelial tip cell staining 
in the postnatal mouse brain 
a-l Labeling of EB-perfused P8 mice with biotinylated IB4 in combination with immunfluorescence (e.g. LN to 
label the basement membrane). Different fixation methods of EB-perfused P8 mice to optimize the combination 
of EB perfusion with IB4 endothelial tip cell labeling and antibody stainings were tested. Combinations of 
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immersion-fixation with 4% FA and different amounts of GA were used. Subsequently, 40 µm coronal brain
sections were labeled with biotinylated IB4 to visualize blood vessel endothelial cells (red) and with an
antibody against LN (green) to test if antigenicity is still present despite GA treatment (a-l,). EB (perfused 
blood vessels, cyan). Whereas postfixation in 4% FA only (no GA) resulted in a considerable loss of the EB
signal (a-d), the combination of 4% FA + 0.025% GA (e-h) or 4% FA + 0.05% GA (i-l) were optimal for 
combination of the different label procedures (IB4, LN) with EB-perfused vessels. 
Scale bars: 50 µm (a-l). 
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Supplementary Figure S2 
Classical endothelial tip cell markers in direct comparison to IB4 labeling in the P8 mouse brain cortex 
Immunofluorescent labeling of 40 µm P8 coronal mouse brain sections labeled with the classical endothelial tip
cells markers VEGFR2 (a-d, green), VEGFR3 (e-h, green) and Dll4 (i-l, green) and with biotinylated IB4 to 
visualize blood vessel endothelial (tip) cells (red). Cell nuclei (DAPI, blue). 
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a-l IB4 as well as antibodies against VEGFR2 (a-d), VEGFR3 (e-h) or Dll4 (i-l) visualize CNS blood vessel
structures and endothelial tip-, stalk-, and phalanx cells. Boxed areas (a,b,e,f,i,j) highlight endothelial tip cells 
that are enlarged on the right hand (c,d,g,h,k,l). White arrowheads (a,b,i,j) mark additional endothelial tip cells
c,d,g,h,k,l IB4+ endothelial tip cells with clearly identifiable, multiple filopodia forming a typical “hand-like” 
structure (c,g,k). Note that neither VEGFR2 (d), VEGFR3 (h) nor Dll4 (l) label endothelial tip cell filopodia as 
accurately as IB4. As filopodia are the key morphological criterion for identifying endothelial tip cells, the
classical tip cell markers VEGFR2, VEGFR3 and Dll4 do not facilitate the identification of endothelial tip cells
in the postnatal mouse brain. Moreover, none of these markers allows a clear delineation of endothelial stalk- or 
phalanx cells from endothelial tip cells (d,h,l). 
Scale bars: 50 µm (a,b,e,f,i,j) ; 10 µm (c,d,g,h,k,l). 
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Supplementary Figure S3 
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Immunofluorescence of perivascular cells in vicinity of endothelial tip cells in the P8 mouse brain cortex 
a-p All samples used for the immunofluorescence shown in this figure have been immersion fixed with 4% FA
and 0.025% GA, which was the final fixation protocol of the present study. This ensures optimal retaining of
EB inside the vessels but also good antigenicity for a variety of cellular markers (see also Supplementary Fig.
S1). For example a-d shows GFAP+ astrocytes and GFAP+ radial glia (green), IB4+ blood vessel endothelial 
cells (red) including an endothelial tip cell and an established blood vessel in the P8 mouse brain cortex.
Endothelial tip cell filopodia do not follow a template of GFAP+ astrocytes and radial glia (a). Boxed area with 
zoom on endothelial tip cell is enlarged in b-d. Cell nuclei (DAPI, blue). e-h PDGFRB+ pericytes (green) and 
IB4+ blood vessels (red) in the P8 mouse cortex. Boxed area is enlarged in f-h. Endothelial tip cell filopodia are 
PDGFRB-. Cell nuclei (DAPI, blue). i-l LN+ (green) common basement membrane of IB4+ blood vessels (red) 
and PDGFRB+ pericytes. Boxed area with zoom on endothelial tip cell is enlarged in j-l. Note the faint LN-
staining of endothelial tip cell filopodia at the base of the endothelial tip cell body (l). Cell nuclei (DAPI, blue).
Note that no pericytes are present at the tip cell (f,h) whereas LN is ensheathing the tip cell body (j,l). m-p 
Nf160+ axons (cyan) and IB4+ endothelial tip cell (red, filopodia) in the P8 mouse corpus callosum. Boxed area
with zoom on endothelial tip cell is enlarged in n-p. Cell nuclei (DAPI, blue). 
Scale bars: 50 µm (a,e,i,m); 10 µm (b-d, f-h, j-l, n-p). 
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